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Abstract

INFORMATION NEEDS AND INFORMATION SOURCES OF PATIENTS DIAGNOSED
WITH RARE CANCERS

By Dana L. Ladd, Ph.D., MS, SLIS

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University

Virginia Commonwealth University, 2016

Major Director: Robin K. Matsuyama, Ph.D.,
Associate Professor, Department of Health Behavior and Policy

BACKGROUND: Approximately 25% of all cancers diagnosed are considered rare. Patients
may face many significant challenges including difficulty obtaining information about their rare
conditions. Patients often have high information needs and may seek desired information from a
variety of informational sources including healthcare providers, media, print, government and
non-profit organizations in order to meet their needs. Accessing reliable consumer-level
information can be challenging and often information needs are unmet. Dissatisfaction with
health information provision can result in negative health-related outcomes and factors including
decreased health-related quality of life.
METHOD: This cross-sectional design study used validated measures to assess the information
needs, information sources, information satisfaction, and health-related quality of life of patients
diagnosed with rare cancers (n=113). Adult patients at the VCU Health Massey Cancer Center

who had been diagnosed with a rare cancer in the past 12 months were contacted via mail survey.
Descriptive statistics were used to summarize patients’ information need and information
received levels. Unmet needs were analyzed using a two-sample T-test. Chi-square tests were
used to analyze information needs and received by demographics for gender and race and logistic
regression analysis was used for age. Descriptive statistics summarized information sources
used and preferred. Finally, descriptive statistics were used to summarize information
satisfaction. The relationship between information satisfaction and health-related quality of life
was assessed using a two-sample T-test.
RESULTS: Study participants had high information needs, particularly for information about
disease, medical tests, and treatment. Though patients also reported receiving information at
high levels, 21 participants (18.9%) reported being unsatisfied with information provision.
Unmet needs were found for information about disease and on the item level for information
about causes of cancer, whether their cancer was under control, expected benefits of treatment,
and financial, insurance, and work-related information. Although participants reported preferring
information from their healthcare providers, they most commonly sought information from the
Internet more than any other source.
CONCLUSION: By identifying patients’ information needs and sources, this study fills an
important gap in the information needs and sources literature of patients diagnosed with rare
cancers. Identification of these needs allows healthcare providers to tailor information provision
to more effectively meet patients’ information needs.

Chapter I. Introduction

According to the National Cancer Institute, in 2016 over 1.6 million people will be
diagnosed with cancer in the United States (National Cancer Institute, 2014). While there are
few patients diagnosed with any one type of rare cancer, approximately 25% of all cancers are
considered rare (Greenlee, Goodman, Lynch, Platz, & Havener, 2010).
Patients with rare cancers face many significant challenges in addition to the attendant
complications of dealing with a potentially life-threatening and life-altering illness (Schaefer,
2012). Patients with rare cancers may have difficulty obtaining a correct and timely diagnosis;
have few or no treatment options; and often lack access to specialists (Schaefer, 2012). In
addition, patients with rare cancers often have difficulty accessing and obtaining consumer-level
information about their types of cancers (Schaefer, 2012). Cancer-related information needs and
sources of health information have been researched in patients diagnosed with common cancers;
however, little is known about the unique health information needs (types of cancer information
sought and desired) and the information sources used and preferred by patients diagnosed with
rare cancers. The research found in the literature that examines the information needs and
information sources of patients diagnosed with a rare disease is often limited to the study of
parents of children with very rare genetic conditions.
A cancer diagnosis in general can have a profound impact on patients, and can result in a
variety of health information needs throughout the cancer care continuum (Rutten, Arora, Bakos,
Aziz, & Rowland, 2005). Many of these patients desire additional information about their
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diagnosis, treatment options, prognosis, coping, complementary and alternative medicine,
relapse, legal and financial, and survivorship information.
Patients with cancer seek information from a variety of sources including healthcare
providers, media, print, government and non-profit organizations, and others to fulfill their
information needs. Most patients, when questioned, prefer to receive health information from
their healthcare provider; however, many report that they actually sought and received
information from a variety of other sources (Rutten et al., 2005; Chou, Liu, Post, & Hesse,
2011).
While patients desire and seek information regarding their cancers or rare diseases, often
information needs are not met. Unsatisfied information needs can result in a variety of negative
associated factors as compared to patients who report information satisfaction (Halkett,
Kristjanson, Lobb, Little, & Shaw, 2012) Decreased trust in physician, decreased satisfaction
with health care, and a low health-related quality of life can result from patients having unmet or
unsatisfied information needs (Halkett et al., 2012). These factors are important to consider as
they have been found to be associated with cancer patients’ treatment adherence and overall
survival (Halkett et al., 2012).
Using a modified version of Johnson’s Comprehensive Model of Cancer Information
Seeking (Johnson, 1997) as a guide, this cross-sectional survey study examines the unique
information needs and information sources used and preferred by patients who have been
diagnosed with rare cancers. Data were collected using validated and reliable measures via mail
surveys of patients diagnosed with rare cancers at the Virginia Commonwealth University
Massey Cancer Center. In addition, this study examines the association between information
satisfaction and health-related quality of life. Overall, this study fills a gap in the rare cancer
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literature as it provides an understanding of the information needs and information sources of
patients with rare cancers, an often overlooked and neglected patient population.
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Chapter II. Literature Review

Definition of Rare Cancer
Before examining the information needs and information sources of patients diagnosed
with cancers, it is important first to have an understanding of the definition of rare cancer and the
various challenges faced by those diagnosed with rare cancers. Many different definitions of
rare cancer have been developed by national and international rare disease organizations, but no
single definition of a rare cancer has been agreed upon. Defining rare cancer is not easy and any
definition of a rare cancer is considered artificial (RareCare, 2014). In general, in the United
States, a cancer is considered to be rare if it affects fewer than 200,000 people. This is the
definition of rare disease used by both the United States Orphan Drug Act and the National
Institute of Health’s Office of Rare Diseases Research (Office of Rare Disease Research, 2014).
The Orphan Drug Act states that “rare” may also be defined as a condition affecting more than
200,000 people but for which drug development will not be recouped from sales of the drug in
the United States (Eslick, 2012).
When studying rare cancers, Eslick (2012) explains that it is necessary to understand the
difference between incidence rate and prevalence rate. Some rare cancers with a low incidence
rate and that are highly curable may have a high prevalence rate due to patients living longer
with the cancer. Conversely, there are common cancers with very poor survival rates that make
their disease prevalence low (Gatta, Capocaccia, Trama, & Martinez-Garcia, 2011). Therefore,
defining a rare cancer using incidence rate rather than prevalence rate accounts for the varying
life expectancy among patients with different types of rare cancers (RareCare, 2014).
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Another consideration related to rare cancers is that they are not only rare histologic
(primary cancer) variants, but also include: 1) subgroups that are difficult to study in common
cancers; 2) common cancers or metastasis in uncommon sites; 3) common cancers in uncommon
hosts; 4) cancers with unusual presenting symptoms, manifestations, or complications; and 5)
cancers that rarely affect a particular age group or population. Delay in diagnosis or
misdiagnoses can occur in these circumstances (Duffy, 2012).
For example, Miller (2010), describing rare subtypes of common cancers, provides the
example of adenoid cystic carcinoma of the breast. While breast cancer is a common form of
cancer in women, adenoid cystic breast cancer is a rare subtype of breast cancer, affecting only
about one percent of those with breast cancer (Johns Hopkins Medicine, 2014). Examples of
common cancers in rare sites include primary extra-ovarian tumors, inflammatory breast cancer,
non-carcinoma breast cancers, ductal carcinoma in salivary glands, and non-cutaneous
melanomas (Duffy, 2012; Greenlee et al., 2010).
Rare cancers can also be common cancers that present themselves in uncommon hosts
such as breast cancer occurring in men (Eslick, 2012; Greenlee et al., 2010). Additionally, some
literature also includes rare cancers that may have uncommon initial symptoms, making
diagnosis difficult. Furthermore, cancers that do not often affect a particular age group, such as
when a pediatric type of cancer occurs in an adult can be considered rare (Calhoun, 1998).
There are other factors that should be taken into account when studying rare cancers. It is
important to know that some rare cancers do attract more media attention and obtain more
funding and research than other rare cancers. An example of this includes malignant
mesothelioma, a rare type of cancer that often affects the pleural tissue that lines the lungs, but
can also affect tissue lining of the stomach, heart, and other organs. Many patients who are
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diagnosed with mesothelioma were occupationally exposed to asbestos. Mesothelioma has had
considerable recent media exposure due to the many class-action, wrongful death lawsuits that
have resulted from workplace exposure and subsequent mesothelioma diagnosis. Often, for these
types of rare cancers, there is a greater awareness of the cancer and generally more information
is available for both physicians and patients.
Individually, rare cancers affect only a very small percentage of people; however,
collectively, rare cancers account for a large percentage of cancers. Miller (2010, p. 46) states,
“Although individual rare diseases may be infrequently encountered, rare diseases in aggregate
affect tens of millions of individuals in the US, Europe and worldwide.” Likewise, Greenlee et
al. (2010) found that 25% of patients with cancers in the United States have a rare cancer. The
research team defined “rare” as being fewer than 150 incident cases per one million per year.
Incidentally, by defining rare cancers as less than 150 per one million, only 11 in the U.S are
considered common: prostate, breast, lung/bronchus, colon, uterine, bladder, melanoma, rectal,
ovarian, non-Hodgkin lymphoma, and kidney/renal pelvis cancer (Greenlee et al., 2010).
Rare cancers are also known as “orphan diseases” as they have been neglected by the
medical and research community for many years (Eslick, 2012). Consequently, due to this longstanding neglect, patients with rare cancers encounter a lack of resources and organizational
support compared to those diagnosed with more common types of cancers.
Rare Cancer Challenges
Gatta et al. (2011, p. 2494) state, “A major problem with rare cancers is that their overall
burden on society has not been adequately estimated, although they are thought to constitute a
major public health problem….Improving the quality of care for these cancers is a public health

18

priority.” In order to provide a brief overview of the significance of having a rare cancer,
outlined below are some of the many challenges encountered by patients with rare cancers.
In addition to the difficulty of dealing with a cancer diagnosis and its attendant impact on
the patient’s health, patients diagnosed with rare cancers encounter many challenges due to the
rarity of their conditions. While there are many rare cancers, few people have any one specific
rare cancer. Consequently, rare cancers are often underfunded and understudied compared to
other more common cancers (“Very Rare Cancers,” 2001). Both epidemiological and natural
history studies of rare cancers are very difficult to conduct due to lack of funding and few
patients to participate in studies (Casali, Bruzzi, Bogaerts, & Blay, 2015). Also contributing to
the difficulties of conducting rare cancer research is a lack of unique International Classification
of Disease (ICD) codes for many very rare cancers (Ayme, Bellet, & Rath, 2015). For example,
angiofollicular lymph node hyperplasia (Castleman Disease), a very rare lymphoma-like disease,
lacks its own ICD code and is coded under a more general ICD code, “lymphadenopathy,” along
with other diseases, making research difficult (Castleman’s Disease Collaborative Network,
2014). Additionally, there are fewer available cancer registries and tissue banks for rare cancer
types than those for more common types of cancers (Schaefer, 2012).
Inadequate diagnostics and physicians’ lack of knowledge of specific rare cancers
(Schaefer, 2012) contribute to late or incorrect diagnoses of rare cancer (Feinberg, Law, Singh,
& Wright, 2013; Jeffries & Clifford, 2009). Furthermore, patients may have difficulty finding
and accessing clinical experts who have the expertise to diagnose the rare cancer. Patients with
rare cancers may have to seek multiple medical opinions and travel distances to consult qualified
experts for a complete diagnostic workup in order to obtain an accurate diagnosis. In a
qualitative study by Jeffries and Clifford (2009) of women with cancer of the vulva (a rare
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cancer), women reported the frustration of delayed and incorrect diagnosis. Many women in the
study expressed shock over a cancer diagnosis after being assured for years that they had a
benign condition (Jeffries & Clifford, 2009). When physicians fail to find a medical diagnosis
for the patients’ symptoms, patients who repeatedly seek medical opinions for their undiagnosed
symptoms may be diagnosed as having a psychosomatic or stress-related condition (Jeffries &
Clifford, 2009).
Patients with rare cancers face additional challenges with regard to receiving timely and
appropriate treatment. Delayed diagnosis, described above, may also result in treatment delays
for the patient. Furthermore, appropriate therapies for the condition may not be available. There
is often a lack of interest in drug development among pharmaceutical companies, with a
limited/small potential market of patients resulting in difficulty recouping costs and few patients
available to participate in existing clinical trials. These factors contribute to limited treatment
options and often no U.S. Food and Drug Administration (FDA) approved therapies for many
rare cancers.
Lack of research and physician knowledge; late and incorrect diagnosis; and insufficient
treatments have a negative impact on patients. These factors contribute to the survival rate of
patients with rare cancers being lower than the survival rate of patients with more common
cancers (Eslick, 2012; Greenlee et al., 2010; Williams, 2011). As Greenlee et al. (2010, p.41)
report, very rare cancers “can be rapidly fatal.”
In addition to the challenges briefly outlined above, patients with rare cancers experience
a lack of accessible and reliable information. Although they desire health information about
their condition, finding authoritative information about rare cancers can be a daunting challenge
(Walker, 2013).
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Furthermore, there is a paucity of research in the literature regarding the health
information needs and information sources of patients diagnosed with rare cancers. Even when
broadening the scope of the search to include information needs of patients with any type of rare
condition, there is very little written regarding this population. Most rare disease research has
been conducted in Europe and focuses on the diagnostic challenges and information needs of
parents of children who have rare genetic disorders (Bouwman, Teunissen, Wijburg, & Linthorst,
2010; Tozzi, Mingarelli, Agircola, Gonfiiantine, & Pandolfi, 2013). In a systematic review of
research of cancer patients’ information needs and sources for finding information, Rutten et al.
(2005, p. 258) state, “Future research should address the limitations identified in past research by
assessing the information needs and sources of large, representative, and diverse samples of
cancer patients, including those with rare cancer diagnoses.” Since this 2005 article, very little
has been written to address the gap of patients’ rare cancer information needs in the research
literature.
General Cancer Patients’ Information Needs and Information Sources
Because of the lack of data available on information needs and sources for patients with
rare cancers, the following examines the types of information sought and sources used by those
in the general (non-rare) cancer patient population.
Information needs. Cancer patients’ information needs vary over the cancer care
continuum (Halkett et al., 2012; Maddock, Lewis, Ahmad, & Sullivan, 2011; Matsuyama, Kuhn,
Molisani, & Wilson-Genderson, 2013; Rutten et al., 2005). Cancer information needs are at their
highest during the diagnosis and treatment phases. (Maddock et al, 2011; Matsuyama et al., 2013;
Rutten et al., 2005). Cancer information needs reduce slightly following treatment, but remain
high throughout the cancer care continuum. According to Matsuyama et al., 2013, p. 100).
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“Information needs may be high because many patients have no experience with cancer at the time
of diagnosis and want information to be able to understand and cope with their cancers.
Information needs decrease over time indicating that patients are able to obtain and process needed
information throughout treatment. However, since their needs for information remain high it
would appear that new needs arise.”
The quantity of information desired also varies from patients desiring no information
about their cancers to those who want to know everything. In a study of cancer website users,
researchers found respondents “wanted information on all aspects of cancer (Maddock et al.,
2011).” In another study, most participants responding to a question about desired information
stated that they wanted “everything, including bad news” for side effects, disease, and chance of
getting worse (Matsuyama et al., 2013). In contrast, Balka, Krueger, Holmes, & Stephen’s
(2010) study of breast cancer patients’ information needs found that some women did not want
any additional information about their breast cancer.
Those patients who desire information have a variety of health information needs. Rutten
et al. (2005) reported categories of informational needs of patients with cancers based upon a
systematic review of the cancer information needs literature. The categories of cancer
information needs outlined in more detail below are: cancer-specific information; treatmentrelated information; prognosis information; surveillance information and health information;
coping and interpersonal/social information; financial/insurance/legal information; and medical
system information.
Cancer-specific information: Cancer-specific information includes information on the
type of cancer, etiology, physical effects, diagnosis, and symptoms of the patients’ specific
cancer (Rutten et al., 2005). A study by Shea-Budgell, Kosarus, Myhill, & Hagan (2014) about
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information needs of 411 patients with general cancers found that 43% reported searching for
information on their specific cancer type. Women in a study of breast cancer information needs
reported desiring breast cancer information to verify existing knowledge of their condition and to
elaborate further on what they already know (Balka et al., 2010).
Treatment-related information: This category encompasses information about the
patient’s treatment, treatment options (Shea-Budgell et al., 2014), side effects, clinical trials
(Maddock et al., 2011), and medication information. Shea-Budgell, et al. (2014) found that the
majority of patients reported that treatment was the most important type of information. In
addition to desiring information about specific treatment options mentioned by the physician,
patients also desire information about all treatment options available for their conditions
(Castleton, Fong, Wang-Gillam, Waqar, & Jeffe, 2010). Cancer patients report searching for
information about treatment options such as chemotherapy, radiotherapy, and surgery. Patients
also desire information about side effects of treatment (Castleton et al., 2010; Chou et al., 2011)
and information about how to manage the side effect symptoms of treatment (Castleton et al.,
2010; Tustin, 2010). A longitudinal study of the information needs of women receiving
radiotherapy for breast cancer found that women desire information about treatment side effects
and the impact of treatment on their overall health and life (Halkett et al., 2012). Beyond
standard treatment options, cancer patients search for information about integrative and
complementary and alternative (CAM) therapy options (Castleton et al., 2010; Rutten et al.,
2005).
Prognosis information: Patients inquire about their prognosis, recovery, and long-term
outcomes (Chou et al., 2011; Rutten et al., 2005; Shea-Budgell et al., 2014), with 58% of cancer
patients reporting they sought information regarding prognosis for their particular types of cancer
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(Castleton et al., 2010). In a study by Balka et al. (2010) using narrative to explore the
information needs of breast cancer patients, many women reported seeking breast cancer health
information for prognosis and long-term life expectancies. One respondent in the study stated, “I
needed to know if I was going to die (Balka et al., 2010, p. 398).”
Surveillance information and health information: Patients with cancer also seek
information about their physical and psychological health, prevention, and early detection
(Rutten et al., 2005). Maddock et al. (2011) report that patients desire information about leading
a healthy lifestyle, including diet and nutrition and engaging in physical activity. Along with
health information, patients with cancer desire information about sexuality and physical
appearance (Rutten et al., 2005). Patients in a study of cancer survivors reported needing
information about sexual functioning and fertility (Kent, Arora, Rowland, Bellizzi, & Forsythe,
2012). Other types of health information included in this category are self-care, recovery, and
post-treatment follow-up care (Rutten et al., 2005).
Coping information and interpersonal/social information: This category includes
information about resources for emotional and spiritual support and how to cope with cancer
(Castleton et al., 2010; Rutten et al., 2005). Although not reported as highly as other information
needs, approximately 9% of general cancer patients need psychosocial information. Patients
may seek information about support groups and desire to meet others diagnosed with their
particular type of cancer (Rutten et al., 2005). Maddock et al. (2011) report patients seek
counseling information and information about support groups that they can join. Rutten et al.
(2005) report that patients need information regarding cancer’s effect on family, friends, and
work and may seek information about how to talk to family members about their cancer.
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Financial/insurance/legal information: Patients with cancer report financial, insurance,
and legal information needs (Rutten et al., 2005). Patients may experience significant costs for
treatment and care not covered by health insurance. Patients, particularly those with rare cancers
may have to travel to consult disease-specific specialists and receive diagnostic tests and
appropriate therapies. Due to illness, patients may also not be able to work or may miss time
from work for medical appointments. This may cause a huge financial impact, and patients may
need information about financial and insurance resources. Patients also report that they need
legal information, which may include information about wills and advance directives (Maddock
et al., 2011; Rutten et al., 2005).
Medical system information: This final category of information needs includes
information about healthcare providers and specialists, experience and qualifications of
physicians and healthcare providers, and information about health care systems (Rutten et al.,
2005). Patients use information sources to assess the credentials of their oncologists and the
hospitals from which they are receiving healthcare services (Tustin, 2010). Patients with rare
cancers may search for cancer-specific specialists.
The above section describes the types of information that patients with cancer report
needing and seeking to fill their information gaps. The section below outlines the different types
of sources which patients want to find information about their cancer and from which they report
receiving information.
Information Sources. Sources of cancer health information include healthcare
providers; media (including the Internet); print and libraries; interpersonal; and cancer
organizations (Balka et al., 2010; Kowalczyk & Draper, 2012; Roach, Lykins, Gochett,
Brechting, & Graue, 2009; Rutten, 2005; Shea-Budgell et al., 2014; Tustin, 2010). Shea-Budgell
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et al. (2014) found that the majority of patients trusted their health care provider as a source of
information compared to all other sources. However, while patients report that they prefer to
receive information from their health care providers, they also seek and receive cancer-related
information from a variety of sources (Chou et al., 2011; Rutten, 2005). Cancer information
sources will be outlined and explained in detail below.
Health care providers: This category encompasses the healthcare team and includes:
physicians (oncologists, general practitioners, surgeons, and radiologists), nurses, and other
health care providers. Rutten’s et al. (2005) secondary data analysis of Health Information
National Trends Survey (HINTS) data found that 27.3% of patients reported receiving health
information from a health care provider. A study by Shea-Budgell et al. (2014) showed that
cancer patients rated their doctor or health professional as the most-trusted cancer information
source over the Internet, family, friends, radio, newspaper, and television. The patients in the
study responded that their preferred source of cancer information is meeting in person with a
health care professional (84%).
Halkett’s et al. (2012) study of breast cancer patients undergoing radiotherapy found that
patients in reported that a consultation with a radiation therapist would be beneficial in order to
receive additional information about radiotherapy. The authors of this study suggest that patients
should be provided with additional information before their radiotherapy appointment.
Media: This category includes the Internet, television, videos, and radio. Rutten et al,
(2005) found that 13.5% report the use of media and 37.1% of those reporting use of media
report the use of the Internet to obtain cancer-related health information. A 2003 HINTS
secondary data analysis found that 38% of cancer patients reported seeking information from the
Internet, more than any other source (Roach et al., 2009). Another secondary data analysis of

26

HINTS 2007 data estimated percentages of respondents’ first choices for accessing cancer health
information and found that 25% responded that the Internet is their first choice (Kowalczyk &
Draper, 2012). Patients reported searching for health information online and using the Internet to
participate in online support groups, read health-related blogs, and email health care providers
for information (Chou et al., 2011).
In contrast to high Internet use, Roach et al. (2009) found only 2% of patients with
cancer reported using broadcast media (television, video) to search for health information.
Likewise, in a study of breast cancer patients, Balka et al. (2009) found that patients rarely report
watching videos to learn more about cancer.
Print: Books, magazines, newspapers, brochures, handouts, and libraries encompass print
sources of health information. Rutten et al. (2005) report that 26.2% of patients use print
materials for finding cancer health-related information. Additionally, patients also report using
the library as a source of information about their cancers (Kowalzyk et al., 2012; Rutten et al.,
2005).
Interpersonal: Sources of interpersonal communication include patients talking to
friends, family, co-workers, clergy, and other patients. Cancer patients report using interpersonal
communication (19%) as a source of health information (Maddock et al., 2011; Rutten et al.,
2005). Of those who use interpersonal communication, 43% report communicating with friends
and family, 31% report using support groups, 20% report seeking information from other
patients, and 6% report that their clergy or church is a source of information (Rutten et al., 2005).
Methods of interpersonal communication, for communicating with fellow patients, are through
online, telephone, and in-person support groups (Rutten et al., 2005).
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Organizations: According to Rutten et al. (2005), this category of information sources
encompasses telephone information services, charitable and professional organizations, and
health care organizations. In addition to raising awareness of general or specific cancers,
organizations provide advocacy, lobbying, research, collaboration, funding, support, and
education (Newlands, 2012). An example of a cancer organization is the American Cancer
Society. Many of the organizations have online webpages that patients can use to access
information and also telephone hotlines for information. Most cancer organizations also provide
access to disease-specific online support groups (Ayme, Bellet, & Rath, 2008). These
organizations may also publish journals with articles and information about cancer.
Information Satisfaction
The American Society of Clinical Oncology (ASCO) and the European Society for
Medical Oncology (ESM) developed the Consensus Statement on Quality Care, a ten-point
statement to ensure quality of cancer care. The first goal of the consensus statement is, “Access
to information.” (The American Society of Clinical Oncology, 2006). The access to information
goal states, “Patients should receive adequate information about their illness, possible
interventions, and the known benefits and risks of specific treatment options.”
The above sections provided an overview of cancer patients’ information needs by
outlining their desired types of cancer health information and the information sources used. This
section examines patients’ met and unmet information needs and overall satisfaction with health
information.
Accessibility to credible, accurate, and authoritative information is imperative for all
patients, including those with rare diseases and cancers, so that they can make informed
decisions about their health. The information that patients find often impacts health care
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decisions (Tozzi et al., 2013). Rutten’s et al. (2005) review of the literature regarding cancer
patients’ information needs found that cancer information provision resulted in many benefits.
These benefits included: an increased patient participation in decision making; increased
treatment satisfaction; increased coping ability (Spring, 2014); reduced anxiety; and better
communication with family.
Moreover, meeting information needs is important, as unmet needs are associated with
negative health-related quality of life (Miyashita, Ohno, Kataoka, Tokunaga, Masuda, & Shien,
2015); high levels of anxiety and depression (Halkett et al., 2012); negative illness perceptions;
and higher negative impact of cancer (Husson Mols, Oranje, Haak, & Nieuwlaat, 2014). General
cancer patients report information needs impact their lives. Likewise, patients with rare diseases
in a study by Huyard (2009) found their informational needs so important that they reported that
it was the physician’s moral obligation to provide them with authoritative, credible information.
Rare disease patients in the study reported their overall health care experience would be
improved if health care providers not only provided an adequate diagnosis, but also provided
adequate information to the patient about the condition.
Meeting cancer patients’ information needs is important; unfortunately, cancer patients
often report that their needs were not adequately met (Rutten, Squiers & Hesse, 2006). In a
study by O’Connor, Coates and O’Neill (2010, p. 275) of 40 patients with rectal cancer, patients
reported having high levels of information needs; however, they reported that their needs were
largely not met. Patients in the study reported receiving inadequate information about testing
and “long-term physical, psychological and social sequelae of the disease.” Likewise, Halkett’s
et al. (2012) study of breast cancer patients receiving radiotherapy found that many of the
women’s specific information needs regarding treatment effects were unmet or only partially
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met. Husson et al. (2014) found that nearly half of thyroid cancer survivors responded that they
were, “not at all,” or “little satisfied” with the amount of information they received about thyroid
cancer, and in particular were less satisfied with information they received about long-term
effects, recurrence, aftercare, and current information about the disease.
Like patients diagnosed with cancer, patients with rare diseases, including rare cancers,
often do not have their information needs met and are dissatisfied with the information they have
received. Many patients with rare diseases report finding it difficult to obtain information about
their rare conditions (Armstrong, Rochnia, Harries, Bundock, & Yorke, 2012; Budych, Helms, &
Schultz, 2012; Feinberg et al., 2013; Huyard, 2009; Lim, Downs, Li, Bao, & Leonard, 2012;
Mooney, Poland, Spalding, Scott, & Watts, 2013).
For example, Huyard (2009) conducted semi-structured interviews of 29 patients and 15
parents of patients diagnosed with rare diseases. The study found that patients with rare diseases
expect not only to be well treated as patients, but to be listened to, taken seriously, and supported
and informed according to need (Huyard, 2009). Patients who reported being dissatisfied with
the diagnosis experience with their physician reported, among other reasons, “inadequate
provision of information about the disease (Anderson, Elliott, & Zurynski, 2013, p. 4).”
In a rare cancer blog entry, Jan Geissler, Director of the European Cancer Patient
Coalition states, “I believe that empowerment of patients is a pre-requisite for health, and access
to high quality health information is fundamental to achieve this. [Patients] regard access to
information as a fundamental right, as long as it meets stringent quality principles. Patients,
especially those with a rare disease, are particularly isolated and vulnerable without effective
access to information” (Geissler, 2010).
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As shown above in examining information satisfaction and met and unmet needs of
cancer patients and patients with rare diseases, meeting patients’ information needs is important
as unmet needs and low satisfaction with health information can be associated with many
negative factors, including reduced satisfaction with care, trust in physician, and health-related
quality of life (Husson Mols, & Van de Poll-Franse, 2011). These three factors are important in
the overall health of cancer patients, as described below.
Patient satisfaction. Varying definitions of “patient satisfaction” exist due to the
difficulty of defining the term “satisfaction” (Williams, Weinman & Dale, 1998). Bredart,
Bottomley, Blazeby, Conroy, & Coens, (2005, p. 2121) define patient satisfaction as, “the extent
to which an individual’s health care experiences match his or her expectations.” Kamo,
Dandapain, Miksad, Houlihan, & Kaplan, (2010) expand this definition to encompass health care
experiences increasing the possibility of the patient receiving favorable health outcomes. In
general, patient satisfaction is used for measuring the quality of health care received by patients
(Prakash, 2010).
The literature shows that patient satisfaction is important because it is related to patients’
following of physician recommendations, cancer treatment adherence, and health status
improvement (Bleich, Ozaltin, & Murray, 2009; Bredart et al., 2005). Bleich et al. (2009) found
that in addition to patient satisfaction being related to increased treatment adherence, patients
who are satisfied with their healthcare experience are generally more compliant and cooperative.
Gupta (2012, p. 766) states, “…there has been a recent rise in awareness that patients’
satisfaction with the quality of the services they receive at a healthcare institution can affect their
treatment outcome.” Results of Gupta’s (2012) study of patients diagnosed with pancreatic
cancer showed that patient satisfaction was an independent predictor of survival.
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Patient trust in physician. While trust is important in any relationship, it is a particularly
integral and important part of the patient-physician relationship (Anderson & Dedrick, 1990;
Hillen, de Haes Hanneke, & Smets, 2011; Kaiser, Rauscher Jacobs, Strensk, Ferrans, &
Warnecke, 2011; Pearson & Raeke, 2000). There are varying definitions of the concept of trust
in a physician. Trust can be defined as the patient’s set of beliefs about how their physician will
perform in a certain way (Pearson & Raeke, 2000). Trust may also be defined more affectively
using the patient’s “reassuring feelings” or “feelings of confidence” in the physician as a basis of
trust (Pearson & Raeke, 2000). Definitions also encompass qualities which patients expect their
physician to possess and can include: competence, compassion, maintenance of privacy and
confidentiality, reliability, dependability, and good communication skills (Pearson & Raeke,
2000). A study by Hillen et al. (2011) found that other components of physician trust among
patients were perceived technical competence, honesty, and patient-centered behavior.
It is important for patients to have trust in their physicians. Pearson and Raeke (2000, p.
512) state, “Theoretically, patient trust should serve to reinforce the functioning of the clinical
relationship as a health partnership, thereby increasing the probability of patient satisfaction,
treatment adherence and improved health status, while decreasing the likelihood of leaving the
physician’s practice or withdrawing from a health plan.” The literature shows that increased
patient trust leads to greater treatment adherence (Pearson & Raeke, 2000; Kaiser et al., 2011;
Hillen et al., 2011); patient satisfaction (Pearson & Raeke, 2000; Kaiser et al., 2011; Hillen et al.,
2011); facilitated communication; medical decision making; and decreased patient fear (Hillen et
al., 2011). In a study of patients with cancer, Hinnen, Pool, Holwersa, Sprangers, and
Sanderman, (2014) found that low levels of trust in physician were associated with increased
emotional distress and increased physical limitations. Kaiser et al. (2011) found that a trusting
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relationship with a regular provider facilitates trusting relationships with other health care
providers on the care team.
Health-related quality of life. Health-related quality of life (HRQL) is the subjective
perception of the patient’s overall wellbeing, encompassing emotional and physical health and its
impact on the patient’s life (European Organization for Research and Treatment of Cancer,
2014). Traditionally, the outcomes of focus were on the narrow measures of mortality and
morbidity (Centers for Disease Control and Prevention, 2011). Now, measures are expanded to
include outcomes of HRQL in addition to morbidity and mortality. This reflects that more people
are living longer with chronic illnesses, including cancers that may have limited treatments but
not a cure (Institute of Health Economics 2008). Thus, with patients living longer with illnesses,
it is essential that their physical, mental, and social lives are also improved.
Measuring HRQL is important because it assesses the positive and negative impacts of
chronic disease and treatment on patients’ overall wellbeing. Additionally, HRQL measures
assess the current health status of the patient. This is vital due to the wide variability of patients’
HRQL even if they have the same disease and are undergoing similar treatment (Institute of
Health Economics, 2008).
HRQL is now considered critical to patient care and researchers are beginning to explore
the relationship between HRQL and patients’ overall survival (Lemonnier, Lewis, Ahmad, &
Sullivan, 2014). In a study of non-small cell lung cancer patients, Efficace, Bottomley, Smith,
Lianes, and Legrand (2006) found that self-reported HRQL provides independent prognostic
information for survival. There was an increase in deaths for those who self-reported worse
HRQL (Efficace et al., 2006).
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Since we know that information access and satisfaction of informational needs contribute
to patients’ well-being, or can positively or adversely affect patients, we must begin to provide
more/credible information for patients with rare cancers. The following section provides the
conceptual framework used for this study that shows health information needs, sources, and
information satisfaction in the context of health-related quality of life.
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Theoretical Framework
This research study draws upon Johnson’s Comprehensive Model of Cancer Information
Seeking (CMIS) to conceptualize information needs and information seeking behavior of
patients with rare cancers. First, an explanation of the CMIS will be presented, followed by the
conceptual model that was used in this study.
Johnson’s comprehensive model of information seeking. The CMIS posits that
antecedents motivate patients to seek information and information carrier factors lead to
information seeking actions. The CMIS model is shown in Figure 1 below and a brief overview
of the model’s constructs will follow.
Figure 1. Johnson’s Comprehensive Model of Cancer Information Seeking

(Johnson, 1997)
Antecedents: The antecedents of CMIS are factors that motive a person to seek
information and are comprised of the concepts of demographics, experience, salience and beliefs.
Demographic Factors: Research has shown that consumers’ usage of sources of health
related information varies by demographic factors (Johnson, 1997). For example, information
searching behavior and information needs vary by age. Rutten (2006) examined informational
needs of cancer patients who actively seek cancer information by socio-demographic status using
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2003 HINTS survey data and found that younger aged cancer patients were more likely to seek
health information than those aged sixty-five or older. Additionally, information seeking varies
by gender. Females are more likely than males to search for cancer information (Rutten, 2005,
2006). Another example of demographic differences is educational level. Those with a college
degree or reporting “some college” are also more likely to seek out cancer health related
information than those who did not report any college experience (Rutten, 2006). Race/ethnicity
also varies between those patients who search for cancer-related information online and those
who do not (Castleton, 2011, Rutten, 2006).
Experience: The second antecedent in the CMIS model is experience. Direct experience
predicts health information seeking. A person’s own symptoms or experience with cancer may
prompt him or her to seek health information. Examples include personally being screened or
treated for cancer and having a friend or family member who is screened for cancer (Johnson,
1997).
Salience and beliefs: Salience and beliefs are motivational factors for seeking health
information to fill a knowledge gap. Salience is the belief that health information will actually
fill a knowledge gap. Beliefs encompass a person’s belief that there is something that can be
done to improve his or her medical condition. If a person believes that there is a medical therapy
available that can improve his or her medical condition or that there is a test that can detect
cancer, the person will seek health information (Johnson & Meischke, 1993).
Information Carrier Factors: First, the term “carrier” in the CMIS model is used to
describe any informational source or information channel (i.e. print, video, physician).
Information carrier factors are the second column of the CMIS model and are comprised of two
concepts: characteristics and utilities.
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Characteristics: This concept describes characteristics that health information seekers
desire in the information sources they are using. For example, characteristics may include source
credibility, editorial tone, or reading level of the information (Johnson, 1997)
Utilities: The second concept of information carrier factors is utility. Utility is related to
the user’s perceived usefulness of the information carrier. Characteristics, described above, make
the information carrier useful. Describing utility, Johnson and Meischke, (1993, p. 349) ask, “…
is the information contained in the medium important for the individual’s purposes, relevant, and
topical?” Utility of the information in CMIS leads to the concept of information seeking actions.
Information Seeking Actions: Antecedents and carrier factors predict information
seeking actions. While the CMIS provides a framework for predicting information actions, it
lacks a final outcome of patient health behavior. Anker, Reinhart and Feeley, (2011) expand the
CMIS model by placing it in the context of health behaviors (see figure 2). This modification of
the CMIS, integrating health behavior, is the basis for the conceptual model for this study (see
figure 3) outlined in detail below.
Figure 2. Information Seeking in the Context of Health Behavior Outcomes
Predisposing
Characteristics

Engagement in
Health Information
Seeking

Associated Health
Behavior Outcomes

(Anker et al., 2011)
Conceptual model describing rare cancer patients’ information seeking. Owing to a
lack of theoretical models explaining information seeking in context of health, the conceptual
model used for this study integrates Anker’s et al. (2011) model into the CMIS to provide a
conceptual framework that incorporates associated health behavior outcomes in addition to
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health information seeking. Figure 3 below demonstrates the model and a more detailed
explanation of the model follows.
Figure 3. Conceptual Framework
Predisposing
Characteristics

Engagement in Health
Information Seeking

Demographics

Characteristics

gender, age, race

Information Types
Information Sources

Associated Health
Behavior Factors

Motivational Factors

Background Factors

Ch

Health-Related
Quality of Life

Direct Experience
Rare Cancer Experience

Utilities
Satisfaction with information

Salience
Desire for health information

Beliefs

In the conceptual framework used to guide this study, “predisposing characteristics”
(called antecedents in the CMIS) are those characteristics that lead or motivate patients with rare
cancers to seek information. These characteristics include demographics and direct experience.
Information seeking varies by gender, age, and race. Direct experience can be defined as a
patient’s experience with rare cancers. Being screened, diagnosed, or treated for a rare cancer
are all considered predictors to seeking information about rare cancers.
The motivational factors of the predisposing characteristics are salience and beliefs.
Salience and beliefs provide the motivators to the background factors to actually engage in
information seeking. If patients with rare cancers believe that there is information about their
rare cancers (salience) and believe something can be done to improve their health, they will
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engage in information seeking. For example, if patients believe there is a treatment available for
their rare cancers, they will seek out information about treatment.
These predisposing characteristics motivate or predict actual engagement in health
information seeking (information carrier factors in CMIS). Health information seeking is
defined as, “the purposive acquisition of information from selected information carriers (Johnson
& Meischke, 1993, p.350).” Engagement in health information seeking is comprised of
characteristics and utilities. Characteristics include information needs (types of information
sought) and sources used.
The second concept of engagement in information health seeking is utilities. Utilities
pertain to the usefulness of the information and answer the questions, “Was the patient satisfied
with the information and did the patient receive information from his/her preferred information
source?” Utilities, measured as satisfaction with information, leads to associated health behavior
factors. In this study the associated health behavior factor being studied is health-related quality
of life. For example, patients with information needs that are not met (unsatisfied information
needs) may report a decreased health related quality of life as compared to patients whose
information needs were satisfied.
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Chapter III. Specific Aims and Research Questions
This research study examines the unique health information needs and sources of
information of patients who have been diagnosed with rare cancers. Due to the lack of
information on rare cancers for patients, this study also examines the relationship between rare
cancer patients’ satisfaction with health information, and their health-related quality of life.
The three specific aims of this study and their associated research questions are:
Specific Aim 1: Examine the information needs of patients who are diagnosed with a rare
cancer.
RQ1: What types of cancer-related health information are desired by patients diagnosed
with rare cancers?
RQ2: Do information needs vary by demographics: gender, age, and race?
Specific Aim 2: Examine the information sources used and preferred by patients with rare
cancers.
RQ3: What sources do patients use to find information about their rare cancers?
RQ4: What sources do patients prefer when seeking information about their rare cancers?
Specific Aim 3: Examine patients with rare cancers’ satisfaction with information and its
association with health-related quality of life
RQ5: Are patients with rare cancers satisfied with the information they receive?
RQ6: Is information satisfaction related to health-related quality of life?
Based upon the literature review detailed above, it is hypothesized that rare cancer
patients’ unsatisfied information needs will have a negative association compared to rare cancer
patients who report having a higher level of information satisfaction. For example, patients who
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report having unsatisfied information needs will report a lower perceived health-related quality
of life as compared to patients who report a higher level of satisfied information needs.
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Chapter IV. Research Design and Methods

Study Overview
This cross-sectional design study used mail surveys to assess the cancer information
needs, information sources, and the relationship of health related quality of life to information
satisfaction of patients diagnosed with rare cancers. Validated measures were used to collect data
on cancer information needs, information sources, and source preferences. Additionally,
validated measures were used to collect data on participants’ satisfaction with information, as
well as patient health-related quality of life. The overall purpose of this study is to describe rare
cancer patients’ information needs, information sources and source preferences, and to determine
whether information satisfaction is associated with health-related quality of life.
Study Site
The study was conducted at the Virginia Commonwealth University Massey Cancer
Center (MCC). The MCC is a National Cancer Institute (NCI) designated cancer center. In
2014, a total of 15,087 patients visited the MCC for consultations and treatments including
chemotherapy, bone marrow transplantation, surgical procedures, and radiation therapy. In
2014, 5,814 new patients were seen comprising a patient population of 57% Caucasian, 38%
African-American, and 5% other races.
List of Rare Cancers
The list of rare cancers used to identify eligible patients is derived from rare cancers
included in the Textbook of Uncommon Cancers (2012) edited by Derek Raghavan MD, Medical
Oncologist and President of the Levine Cancer Institute at Carolinas Health Care System. The
textbook editorial board is comprised of six other oncology specialists, in addition to Dr.
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Raghavan. The cancers included in the text were selected by oncologists in each cancer specialty
area, with 198 cancer specialists contributing information. Each oncologist was responsible for
identifying rare cancers in his/her area of specialty. All cancers, other than cancers identified in
the pediatric cancer sections of this book were included in the rare cancer list used in this study.
Additionally, the compiled cancer list used for this study includes cancers from the Office
of Rare Disease Research (ORDR) rare cancer list that were not included in the Textbook of
Uncommon Cancer. Diseases on the ORDR list were included if they were an unusual cancer
cell type. The following disease types on the ORDR list were excluded: those that are not
specific cancer types; hereditary syndromes; syndromes that are not cancers but increase cancer
risk; and precancerous conditions. Cancers were also excluded if they were exclusively pediatric
cancers. Laurie Lyckholm, MD, Professor, Department of Hematology/Oncology, Holden
Comprehensive Cancer Center, University of Iowa, assisted with the development of the rare
cancer list that is included in this study and the inclusion/exclusion criteria for selecting cancers
from the ORDR list. The list was comprised of approximately 500 different types of cancers that
are considered rare.
This study was approved by the Virginia Commonwealth University (VCU) Institutional
Review Board.
Study Sample
Inclusion criteria. Eligible participants (N = 113) were patients diagnosed with rare
cancers of any type or stage being treated by a medical oncologist, radiation oncologist, or
surgical oncologist at the MCC. Eligible patients must have been diagnosed within twelve
months prior to being contacted for participation, aged 18 years or older, and fluent in the
English language.
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Exclusion criteria. Patients who did not have a diagnosis of a rare cancer were excluded
due to this study specifically examining the information needs and information sources of those
patients who have rare cancers. Patients who were diagnosed more than twelve months
previously were not eligible because they may have satisfied a greater number of information
needs given the length of time since diagnosis or may have forgotten their information needs,
resulting in response bias. Patients younger than 18 years of age were also excluded from this
study as this study seeks to examine the information needs and sources of adult patients, not that
of children or the parents of children with cancer. Those who were not fluent in the English
language were excluded since all measures used are written exclusively in the English language.
Those patients known to be incarcerated currently or incarcerated at the time of diagnosis were
also excluded from the study. Finally, patients were also excluded if they were deemed not
appropriate for contact or participation by his/her oncologist.
Recruitment. A HIPAA partial waiver of authorization to use protected health
information (PHI) was approved by the VCU IRB for purposes of identifying patients eligible to
participate in the study.
To identify eligible participants, the researcher collaborated with Massey Data Analytics.
The rare cancer list was used to match patients listed in the Massey Cancer Center cancer patient
registry which is provided by the Massey Cancer Center Cancer Informatics Core and is updated
on a six-month time delay from the patient’s date of diagnosis. Each month, Massey Data
Analytics emailed the researcher a password protected Excel spreadsheet containing a list of
patients who were diagnosed with a rare cancer included in the rare cancer list and who met all
eligibility requirements. Patients who were known to be deceased were excluded. Patients were
determined to be deceased based upon VCUH hospital billing data, the Social Security Death
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Index Data, and the cancer registry data vital status. Prisoners at the time of diagnosis and those
currently incarcerated were also excluded. Prisoner status was determined by payer status listed
as, “corrections,” and the latest available address in the billing data or registry data. The list of
patients meeting eligibility criteria was also matched against prior lists sent to the researcher to
exclude patients previously included in the rare cancer patient list. The MCC data analytics’
spreadsheet contained the following information: medical record number, patient name,
diagnosis date, primary cancer site description, histology description, grouped histology
description, behavior code (malignant), cancer stage, treatment status, and patient address.
In advance of mailing survey letters, the researcher contacted Massey Cancer Center
oncologists and nurse practitioners via email and provided them details of the study. The
oncologists and nurse practitioners were asked to contact the researcher if they had questions
about the study, did not wish survey letters to be mailed to specific patients, or if they did not
wish us to contact any of their patients with rare cancers.
This study used mail surveys to assess the information needs and information sources
used by patients who have been diagnosed with rare cancers. The process for implementing the
mail surveys followed the Tailored Design Method (Dillman, 2014) formerly known as the Total
Design Method (Dillman, 1978). The Tailored Design Method uses concepts from social
exchange theories and tailored design to motivate people to respond to written surveys. The
Tailored Design Method promises a high response rate of at least 80% when following the
specific detailed steps for conducting mail surveys (Dillman, 1978, Hoddinott S, Bass, 1986).
By following this method, Hoddinott & Bass (1986) achieved a mailed survey return rate of
92.8%. The Tailored Design Method steps employed in this study are described below.
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A timeline of mailings is found in Table 1 below. A preliminary introductory letter
(Letter 1) was sent to all eligible patients introducing them to the study and providing a brief
overview and contact information (phone number and email address) for them to opt out of
participating in the study or to ask questions. Patients opting out were not sent any further letters
regarding the study. Letter 1 also informed patients that they would be receiving a survey in the
mail along with a written letter of request for participation in approximately one week. All
patient and return addresses for the envelopes were hand-written and all letters and envelopes
used VCU School of Medicine letterhead.
One week after mailing the introductory letter, an initial invitation letter/packet (Letter 2)
was mailed to the patient. This contained a cover letter providing more details about the study,
the survey booklet, a self-addressed stamped return envelope, and $2.00. The cover letter stated
that by completing and returning the questionnaire, the patient was consenting to participate in
the research study. The letter provided contact information, both telephone and email for the
patient to ask additional questions about the study or to opt out of the study. The survey booklet
contained all of the survey questions which were logically arranged in an easily understandable
style (see appendix A). The survey booklet cover was tailored to the audience of patients
diagnosed with rare cancers by using images to which they can relate. The survey was designed
to be inviting to the patient, as well as easy to complete. The survey booklet contained a unique
individual identification number at the bottom of each page linking to each patient. This
identification number was used to avoid sending mailings after the thank you/reminder letter
(letter 3) to those who had completed and returned the survey. A self-addressed stamped return
envelope was included to lessen the burden on patients in returning the survey booklet. The
return address was written on the final page of the survey booklet in case the participant lost the
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return envelope. The last item included in the packet was a token $2.00 as a “pre-thank you”
incentive for completing and returning the survey that patients could keep regardless of whether
or not they actually completed and returned the survey.
A week after mailing the initial invitation packet, a thank you/reminder letter (Letter 3)
was mailed to everyone regardless of whether or not the patient had returned the survey unless
they had opted out of participating in the study. This letter served to thank those who had
responded and also reminded those who had not yet completed and returned the survey to do so.
Fourteen days following the thank you/reminder letter, a follow-up reminder packet
(Letter 4) was sent to the patient if he/she had not responded by that time. This packet included a
brief overview letter, an identical copy of the survey booklet with the patient’s unique
identification number at the bottom of each page, and another self-addressed, stamped return
envelope. This letter served as a reminder and also included another survey and return envelope
in case the original survey had been lost or discarded.
A final reminder (Letter 5) was mailed four weeks after the follow-up reminder packet
was sent to patients who had not yet returned their surveys. This letter served as a reminder to
complete and return the survey and to let the patient know that we would not be contacting
him/her further regarding the study. Applying the Tailored Design Method process, this letter
was sent using priority mail. The purpose of a different mail delivery format is to pique the
attention and interest of the recipient, emphasize the importance of the letter, and increase the
likelihood that the survey would be completed and returned.
All patients deemed eligible to participate were sent letters 1-3 unless they had contacted
us following Letter 1 requesting to opt out of further participation. Those not responding
following Letter 3 were sent follow–up letters (Letters 4 and 5). Letters 1-3 also followed the
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timeline suggested by the Tailored Design Method. Due to a back-up in receiving mail at the
university, completed surveys were delivered in large batches of ten or twenty, rather than
individually as they arrived at the post office. These mail batches arrived in infrequent intervals,
approximately every six to eight weeks. Due to this mail delivery constraint, and by strictly
following the Tailored Design Method suggested time frame, some patients were sent Letter 4
(which contained an identical survey) when they had already completed and returned the first
survey sent with Letter 2. This led to confusion and three patients returned both the first survey
sent to them and the reminder survey. As a result, we adjusted the time frame for mailing Letters
4 and 5 based upon the return rates of surveys. Letter 4, which included the reminder survey,
was not sent until after approximately 50% of the surveys sent following Letter 3 were received.
The final letter, Letter 5 was sent approximately eight weeks following Letter 4 to allow time to
receive surveys in the mail. This was intended to reduce participant confusion and ensure we no
longer received duplicate surveys.
Table 1: Timeline of mailings following the tailored design method
Letter

Description

Mailing
Timing
(weeks)
1

Letter 1

Introductory Letter

Letter 2

Recruitment Letter and
Survey

2

Letter 3

Thank You/Reminder Letter

3

Letter 4

Reminder Letter and Survey

5

Letter 5

Final Reminder Letter
Priority Mail

9

Data received from the returned surveys were entered via key punch method into an
Excel spreadsheet. Because three surveys were duplicates that arrived in batches (without a date
postmark on the envelopes) it was difficult to determine which was the first survey the
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participant completed, so the researcher randomly selected one from each set of duplicates and
entered the data received from the randomly selected surveys into the spreadsheet. The duplicate
survey was stapled to the back of the survey used for data entry and was marked, “duplicate.”
Upon completion of data collection and data entry, data were then imported into JMP (Version
12.0) statistical software for analysis.
Meeting recruitment goals. A plan was made for meeting recruitment goals. According
to the MCC patient census records, a conservative estimate of 1030 patients (13.83%) were
diagnosed with rare cancers listed on the Office of Rare Disease Research cancer list over a
three-year time period, corresponding to an average of approximately 343 rare cancer patients
annually eligible to participate in the study. Assuming a conservative estimate of a 50%
participation rate, 172 patients annually were likely to participate in this study. This means that
the needed sample size (N=100) for this study would easily be met. Attrition was not a
consideration because the subjects were only surveyed at one-time point.
Sample Size and Power Analysis
Based upon the power analysis, a final sample size of 100 was used for this study. The
power analysis calculations were based on research question number two, “Do information needs
vary by demographics (gender, age, and race)?” since this research question requires the largest
sample size to detect a significant effect. The sample size of 100 provides 97% or higher power
to detect medium or moderate (range: .23 - .38) effect sizes. The power analysis type 1 error rate
was .05.
Data Collection Procedures and Measurement
The mail survey session was anticipated to take approximately ten to fifteen minutes to
complete. By completing and returning the survey, patients were informed they were consenting
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to participate in the study. Data were collected on: 1) socio-demographics; 2) cancer information
needs; 3) patients’ received information and information satisfaction; 4) information sources
used and preferred; and 5) health-related quality of life.
Variables and Measures
The following socio-demographic data were collected from the patient via survey:
gender, age, race, type of medical insurance coverage, employment status, and income.
Description of Measures and Scoring (See appendix A for the survey containing measures and
questions used in this study)
The European Organization for Research and Treatment of Cancer (EORTC) Quality of
Life Questionnaire-Information scale (EORTC QLQ- (Information) INFO25).
Cancer Information Received, Information Needs, and Information Satisfaction were assessed
using standardized and modified questions from the European Organization for Research and
Treatment of Cancer (EORTC) Quality of Life Questionnaire-Information scale (EORTC QLQINFO25). The EORTC QLQ-INFO25 measure is valid and reliable. The instrument correlated
with the EORTC Cancer Inpatient Satisfaction questionnaire (IN-PATSAT32) (r>.40), showing
convergent validity and had a low correlation with the EORTC general cancer scale (EORTC
QLQ-C30) showing divergent validity. Internal consistency (Cronbach’s alpha>0.90) of all
items combined proved reliability of the measure (Arraras, Greimel, Sezer, Chie, & Bergenmar,
2010). The measure has been used in studies of patients with various types of cancers and in
culturally diverse populations (Arraras et al., 2010; Husson et al., 2014).
Cancer Information Received: This 25 question instrument asks the stem question, “During your
current disease or treatment, how much information have you received on…” followed by health
information types such as “diagnosis,” “treatment,” and “procedures.” Question responses are
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measured on a four point Likert-type scale anchored by 1 (not at all) on one end and 4 (Very
much) on the other.
In order to assess additional information received, four stem questions were added to this
measure: 1.) The effects of treatment on fertility (the ability to have a baby); 2.) Other treatment
options; 3.) Financial, insurance, and work-related resources; and 4.) Whether family members
are at risk for cancer.
Cancer Information Needs: In addition to the above questions that assess information
provision, the EORTC QLQ-INFO25 questions were modified to assess information needs. The
questions in this instrument were modified to ask, “During your current disease or treatment did
you/do you need information on…” Responses for these questions are on a four point Likert-type
scale anchored by 1 (not at all) on one end and 4 (Very much) on the other.
Information Satisfaction: Information satisfaction was also assessed using the EORTC
information received question, “Were you satisfied with the amount of information you
received?” This question was modified to “Overall were you satisfied with the information you
received?” to assess general information satisfaction. The original EORTC information
satisfaction question was on a four-point Likert-scale ranging from “not at all” to “very much.”
The response options for this survey were dichotomized to a “Yes” or “No” response for ease of
response for participants and to facilitate analysis.
EORTC QLQ- INFO-25 Scoring:
Scoring EORTC QLQ-INFO25. Following directions from the manual, scores for both
information needs and information received were linearly transformed into a 0-100 scale. First, a
raw score, which is the mean of the component items was calculated for each scale: information
about disease, information about medical tests, treatment, other services, different places of care,
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and things you can do to help yourself. The raw scores were then linearly transformed into a 0100 scale. Higher scores indicate a higher information need and higher information received.
Raw Score (RS)=(I1+I2…In)/n
Where I=component item (Likert-score) and n=the number of questions included
in the scale
Linear Transformed Score (S)={RS-1}/range}*100
The range equals the maximum possible response value minus the minimum possible response
value. Therefore, a 1-4 response scale’s range is equal to 3 and the range for any yes/no (binary)
response items is 1.
Following the EORTC QLQ-INFO25 manual, missing data were set to missing if more
than half the data were missing from a particular participant for the particular scale being scored.
Also, any single item was set to missing if not answered. If less than half the data for the scale
were missing, then the missing data were imputed by simply ignoring the missing data and
calculating the raw score by dividing by the number of questions in the scale that have a
response. For example, if item 3 is missing then, RS=(I1+I2+I4)/3.
Each individual information item was also transformed into a 100-point score. For each
information item (individual questions), raw scores, (since they only consisted of one item) when
converted using the formula above were essentially the Likert response score. The raw score
was linearly transformed into a 100-point score using the same formula as above. Due to these
being single questions only, data were unable to be imputed, so any missing items were set to
missing in the database.
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The Health Information National Trends Survey (HINTS). Information Sources and Source
Preferences were ascertained using modified questions from the Health Information National
Trends Survey (HINTS) developed by the United States National Cancer Institute. HINTS is a
national survey that collects data regarding the use of cancer-related information in the United
States. The HINTS survey has been administered in 2003, 2005, 2007, 2011 2012, and 2013.
HINTS survey questions are derived from pre-existing national surveys and created by the
HINTS program in 2001 (Nelson, 2004). Psychometric properties of the questions used in the
HINTS survey are ensured through careful testing of each item (Health Information National
Trends Survey [HINTS], 2014; http://hints.cancer.gov/faq.aspx). It is a standardized and
accepted measure (Nelson, 2004). HINTS 2003 and 2005 were administered solely via telephone
with questions being read to respondents and in 2007 HINTS was administered in two modes:
via telephone and mail (Health Information National Trends Survey, 2014). The questions used
in this study were taken from the HINTS “Cancer Communication” section and focus on cancer
information sources.
One HINTS question included in the survey provides a list of sources and asks the
participant to respond by indicating all the sources from which they sought information the first
time they looked for information. This question was included in this study’s survey followed by
two added questions (that are not in the HINTS survey) using the same sources listed in the
HINTS question. These two modified questions ask what sources the patient has used to seek
information; and the second modified question asks where the patient prefers to receive
information. The following list of sources from the HINTS survey was included for patients to
select: books; brochures and pamphlets; cancer organization; family; friend/co-worker; doctor or
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health care provider; Internet; library; magazines; newspapers; telephone information number;
complementary, alternative, or unconventional practitioner; and other (specified).
HINTS scoring: Responses for this measure were reported as frequencies and percentages.
Health-related quality of Life
The Short-Form Health Survey (SF-12 v.1). Health-Related Quality of Life was assessed using
the Short-Form Health Survey (SF-12 v.1) (License # QN035780) (Ware et al., 1996), a reduced
instrument of the longer 36-item Short-Form Survey (SF-36) from the Medical Outcomes Study.
The SF-12 measures two domains of quality of life: mental health and physical health. It
correlates well with both the SF-36 physical component (R2 =0.911) and the mental component
(R2=0.918). The 12-item measure is both valid and reliable (Cronbach’s alpha>.80). The item
response options are on a five-point Likert-scale ranging from 1 (excellent) to 5 (poor). The SF12 has been used in multiple studies to assess health-related quality of life in cancer patients
(Hamoen, De Rooij, Witjes, Barentsa, & Rovers, 2014; Neuner, Zokoe, McGinley, Pezzin, &
Yen, 2014).
SF-12 v.1 Scoring:
Scoring for the SF-12v.1 was conducted using the client version 5.0 desktop scoring software
provided by Optum (https://campaign.optum.com/optum-outcomes/what-we-do/healthsurveys/sf-12v2-health-survey.html). The scoring software allows for missing score estimation
and calculates both the physical component and mental health component scores of the SF-12
Health Survey. The software uses norm-based scoring, with the norm equaling 50. Higher
scores indicate better health for both the physical health component and the mental health
component, where lower scores indicate worse health for both physical and mental components.

54

Analysis Plan
Surveys and letters mailed and received are reported. The date mailed for each group of
surveys sent is reported along with the number of letters sent for each mailing (letters 1-5). The
number of surveys returned for each group is reported with frequencies and percentages. The
number of patients reported by a family member as having died is reported for each group with
percentages. Finally, the frequency and percentage of patients who requested to opt out of
participating in the survey for each mailing group is reported. The participation rate is reported
as frequency and percentage.
Descriptive analyses were used to characterize participant demographics: gender, age,
race, employment status, insurance coverage status, and household income. Categorical variables
(e.g., race, gender, employment status, insurance coverage and household income) are reported
with frequency and percentages. Continuous variables: age, information needs scaled scores,
information received scaled scores and health-related quality of life scores are reported with
means and standard deviations.
JMP (Version 12.0) was used for all analyses. The significance level for all analyses is
α=.05. Below are the research questions along with the statistical analyses that were used for
each.
RQ1: What cancer-related health information is sought by patients diagnosed with rare
cancers? Descriptive statistics were used to summarize the data regarding the health information
that was reported needed and received by participants. Each cancer-related information type was
listed with the corresponding percentages of information types reported that were needed by
participants and the same was done for information reported received. The data are listed in two
frequency distribution tables (one for information needs and another for information received)
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that included the type of information; number of respondents reporting each type; and percentage
of respondents reporting each type of information for each response: “not at all, “a little,” “quite
a bit,” and “very much.” The mean scaled scores for each subscale and item are also reported
with standard deviations.
Unmet needs. The difference in information needs and information received (unmet
needs) was scored by calculating scale scores for information needs and information received for
each subscale: disease subscale, medical tests subscale, treatment subscale, other services
subscale, and the individual items: different places of care, and things you can do to help
yourself get well. The same was done for each of the individual information need and
information received items. For each subscale and individual item, the average raw score and
scaled score are reported. Additionally, each information need items and each information
received items were linearly converted.
As previously described, larger mean scores indicate greater information needs or greater
information received. To calculate unmet needs, the scaled score means of information received
was subtracted from information needs scaled score means. A positive value indicates that
information needs were greater than information received. A negative value indicates higher
amount of information received than needed.
Information needs and received scales’ means were compared. A two-sample T-test was
used to test the null hypothesis that the information needs and information received scales’
means are equal against a two-sided alternative hypothesis that the means are not equal. Data
were assumed normal based on the Central Limit Theorem given that n>30. A Brown-Forsythe
test was conducted to check for equal variances. If variances were not equal a Welch’s test was
used. Information needs and received means for each scale are reported with the standard
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deviation. Differences between the means are reported with standard error, 95% confidence
intervals, and p-value. In addition to comparing the means of the information needs and
information received scales, means were also compared at the individual item level for all 23
information need items and information received items using the same analyses as outlined
above for the information subscales.
RQ2: Do information needs vary by demographics: gender, age, and race (Whites and nonWhites).
Information needs. Information need levels were dichotomized into low needs and high needs.
“Not at all” and “A little” were scored as 1 (low needs) where “Quite a bit” and “Very much”
were scored as 2 (high needs). For the binary variables of gender (male and female) and race
(White/non-White), a two sample Pearson chi-square test was used to compare the difference in
the two groups’ proportions of information needs. The null hypothesis that the proportion of no
difference in level of need is tested against an alternative hypothesis that there is a difference in
need level proportions. A Fisher’s Exact test was used to assess differences if any group
contained fewer than five subjects. For information need subscales and items, the number of
subjects reporting high information needs and the number reporting low needs with a group total
is reported. The proportion of those reporting high needs is reported with the proportion
difference between the two groups (i.e. male high needs versus female high needs) and their
associated 95% confidence intervals. The Chi-square test statistic, degree of freedom and p-value
are also reported. If Fisher’s Exact Test was used then no test statistic is reported, only the pvalue.
Logistic regression was used to test for a relationship between the continuous variable
age and level of information needs. Age was measured in whole years. Participants were
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indicated as having either high information needs or low information needs. Age was
summarized for each information need level with sample sizes, means, standard deviations, and
confidence intervals. Group high needs were summarized with frequencies and proportions.
Parameter estimates, standard error, test statistics, p-values, and 95% confidence intervals are
used to describe the change in odds of having high information needs due to a one-year increase
in age. Data were assumed normal and each observation is independent. Linearity was assumed
after the logit transformation.
Information received. Like information needs, information received was also
dichotomized into “high amount of information received” and “low amount of information
received” The same statistical analyses (chi-square test for the binary variables gender and race
and logistic regression for the continuous variable age) were also used to assess if information
received levels (high and low) vary by demographics: gender, age, and race (Whites/nonWhites). Pearson’s chi-square was used to assess the null hypothesis that proportion of high
levels of received information for males is equal to the proportion of high levels of received
information for females against the alternative hypothesis that the two groups’ proportions are
different. The same analysis was conducted for proportions of received information for Whites
and non-Whites. Logistic regression was used to test for a relationship between age and level of
information received.
RQ3: What sources do patients use to find information about their rare cancers? Descriptive
statistics were used to summarize the sources used by participants to find information about their
rare cancers. The frequency and percentage of those who reported looking for information is
described. For each type of source (physician, print, Internet, friends, etc.) corresponding
frequencies and percentages of patients reporting use are reported. The data are listed in a
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frequency distribution table that includes: each source; number of respondents reporting using
each source; and percentage of respondents reporting using each source.
RQ4: What sources do patients prefer when seeking information about their rare cancers?
Descriptive statistics were used to summarize the data regarding preferred informational sources.
For those who report searching for information, each type of source (physician, print, Internet,
friends, etc.) is listed with the corresponding frequencies and percentages of source preferences
reported by participants. The data are listed in a frequency distribution table that includes: source
type; number of respondents reporting the source as preferred; and percentage of respondents
reporting the source as preferred.
RQ5: Are patients with rare cancers satisfied with the information they receive?
Descriptive statistics were used to summarize the data regarding participant satisfaction for
information they received. Frequencies and percentages for each category (“Yes” and “No”) for
the questions, “overall were you satisfied,” “did you desire additional information, and “did you
desire less information” are reported. Perceived helpfulness, searching confidence, amount of
effort to find information, frustration level, difficulty of information, concern about quality, and
source trust are all reported on a Likert-type scale. Frequencies and percentages for each
response category are reported. For all questions, frequencies and percentages are listed in a
distribution table with number of respondents for each category and percentages of patients
reporting each.
Information satisfaction/dissatisfaction differences by gender, race and age are also
reported. A chi-square test was used to analyze differences in proportions of information
dissatisfaction between males and females and to analyze differences between White and nonWhite participants. The frequency of reporting satisfaction and dissatisfaction are reported for
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each group with the group totals, group portions reporting dissatisfaction, proportion differences
and 95% confidence intervals, Chi-square test statistic, degrees of freedom and the p-value.
Logistic regression was used to assess the relationship of age and information satisfaction.
RQ6: Is information satisfaction related to perceived health-related quality of life? A ttest was used to test the association between information satisfaction and perceived healthrelated quality of life. A two-sample T-test was used to test the null hypothesis that the perceived
health-related quality of life mean scores of patients reporting information satisfaction and those
reporting dissatisfaction with information are equal. This was tested against a two-sided
alternative hypothesis that the mean health-related quality of life scores is not equal between the
two groups. Mean comparisons were conducted for both the physical health component scores
and the mental health component scores of the SF-12 Health Related Quality of Life Measure.
Data are assumed normal using the Central Limit Theorem: n>30. A Brown-Forsythe
test was conducted to check for equal variances. If variances were not equal a Welch’s test was
used. Mean scores and standard deviations for the physical component of health-related quality
of life and the mental health component are reported for both the information satisfied group and
the dissatisfied group. Differences between the means are reported with standard error, 95%
confidence intervals, and p-value.
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Chapter V. Results

Survey Mailings
Data collection began in October 2015 and was completed in May 2016. Table 2 below contains
a timeline of letters and surveys sent and received. A total of 199 patients were identified as
having a rare cancer and were asked to participate in the study via mailed survey. Letter 1 was
mailed to a total of 199 patients identified as having a rare cancer. Letters 2 and 3 were mailed to
all patients unless the patient or patient’s doctor contacted us opting out of the study or if a
patient’s spouse contacted us informing us of the patient’s death. Letter 2 was sent to 197
patients and Letter 3 was sent to 195 patients. Those not returning the completed survey and who
had not opted out were then mailed follow-up letters. Letter 4 was mailed to 68 patients and of
those not responding, 48 were sent the final Letter 5.
Of the 199 surveys mailed to patients, 113 were returned resulting in a 56.7% overall
response rate. Six patients were reported as being deceased (3.0%), three surveys were returned
as undeliverable (1.5%), and six patients opted out of participation (3.0%). Of the resulting 184
eligible patients, 61.4% participated in the study.
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Table 2. Letters and surveys sent and received
Group
#/Date of
First
Mailing
1
(10/25/15)

Letter1
# Sent

Letter2
# Sent

Letter3
#Sent

Letter4
#Sent

Letter5
#Sent

Surveys
Received
Frequency,
(%)
46
(54.1%)

Patients
Deceased

Returned as
Undeliverable

Requested
to opt out
of study

85

85

85

45

32

2
(11/12/15)

12

12

12

8

3
(11/27/15)
4
(12/2/15)
5
(1/13/16)
6
(2/13/16)
7
(2/29/16)
8
(3/23/16)
TOTAL

13

13

13

17

17

15

Participation
Rate
Frequency
( %)
46/77
(59.7%)

3

3

2

8

4 (33.3%)

0

0

0

4/12
(33.3%)

6

3

9 (69.2%)

1

0

0

17

9

5

0

0

1

14

14

-

-

1

0

1

19

18

18

-

-

0

0

1

25

25

24

-

-

0

0

1

13

13

12

-

-

11
(64.7%)
8
(53.3%)
10
(52.6%)
17
(68.0%)
8 (61.5%)

1

0

0

199

197

195

68

48

113
(56.7%)

6
(3.0%)

3
(1.5%)

6
(3.0%)

9/12
(75%)
11/16
(68.7%)
8/13
(61.5%)
10/18
(55.5%)
17/24
(70.8%)
8/12
(66.6%)
113/184
61.4%

Demographics
Socio-demographics of the sample are reported in table 3. Fifty-one respondents were
male (45.1%) and 62 were female (54.9%). The mean age of the sample was 59.0 years,
(SD=15.90). Of those responding, 69.9% self-identified as White/Caucasian, 25.7% as
Black/African American, and 4.2% other races. Less than 2% identified as Hispanic or Latino.
The majority of the sample reported being retired (44.1%) and thirty-one participants (27.9%)
reported working full-time. Twenty-one respondents (18.6%) reported a mean annual household
income of greater than $100,000. Most participants reported having employee sponsored health
insurance (40.7%) followed closely by Medicare coverage (32.7%). Appendix C contains tables
listing participants’ cancer types, sites, and stages by demographics.
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Table 3. Demographics
n=113
Age, Years

Mean (SD)
59.0 (15.90)
Frequency (%)

Gender
Female
Male
Race
Black or African American
White or Caucasian
Asian
Native American or Alaska Native
Native Hawaiian/Pacific Islander
Multi-Racial
Other
Hispanic or Latino Origin
Yes
Employment Status (n=110)
Full-time paid
Part-time paid
Retired
Unemployed
Homemaker
Medical Insurance Coverage (n=112)
None
Private insurance
Employer sponsored insurance
Self-pay
Medicare
State-sponsored insurance
Virginia Coordinated Care
Medicaid
Military
Not sure
Other
Total Household Income (n= 108)
Less than $5,000
$5,001-$10,000
$10,001-15,000
$15,001-$20,000
$20,001-$25,000
$25,001-$30,000
$30,001-$40,000
$40,001-$50,000
$50,001-$60,000
$60,001-$70,000
$70,001-$80,000
$80,001-$90,000
$90,001-$100,000
Greater than $100,000

62 (54.9)
51 (45.1)
29 (25.7)
79 (69.9)
1 (.89)
0 (0)
0 (0)
2 (1.8)
2 (1.8)
2 (1.8)
31 (27.9)
11 (9.9)
49 (44.1)
13 (11.7)
6 (5.4)
3 (2.7)
14 (12.4)
46 (40.7)
0 (0)
37 (32.7)
1 (0.9)
1 (0.9)
7 (6.2)
1 (0.9)
1 (0.9)
1 (0.9)
4 (3.5)
8 (7.1)
6 (5.3)
5 (4.4)
2 (1.8)
6 (5.3)
5 (4.4)
14 (12.4)
9 (8.0)
12 (10.6)
9 (8.0)
2 (1.8)
5 (4.4)
21 (18.6)
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Information Needs
Below are the mean score results for each information need for the four information need
subscales with scores for each of the items comprising the scale. Table 4 shows each of the
subscale scores’ means and standard deviations and each of the 23 items included in the
information needs scale. Information need items are reported with respondent frequency and
percentage reporting needs on a Likert scale from 1 (not at all) to 4 (very much). The Likert scale
for each subscale and each item was converted into a 100-point scale called the scaled score.
Scores for each are continuous ranging from 0 indicating low need to 100 indicating high
information need.
Information about disease. The mean information need score for the subscale,
“information about disease” was found to be high at 74.62 (SD=23.8). Four items comprise this
subscale with the following mean level of information need: “diagnosis about your cancer”
(M=79.0 SD=28.8); “the extent of your cancer” (M=72.4, SD=33.1); “the possible causes of
your cancer” (M=64.8, SD=34.8); and “whether the cancer is under control” (M=81.8, SD=28.8).
Information about medical tests. Participants had a high mean information need score
for the subscale, “information about medical tests” (M=69.7, SD=28.9). Three information need
items comprise this subscale with the following mean level of information need: “the purpose of
medical tests” (M=68.2, SD=33.0); “the procedures of the medical tests” (M=65.8, SD= 33.3);
and “the results of the medical tests” (M=75.5, SD= 28.4).
Information about treatment. The “information about treatment” subscale was also
found to be high with a mean score of 64.8 (SD=26.31). This subscale included six items. The
mean information need scores for the items were: “treatment modality” (M=76.6, SD=32.0);
“expected benefit of treatment” (M=80.0, SD=28.9); “possible side effects of treatment”
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(M=75.7, SD=31.4); “expected effects of treatment on symptoms” (M=74.6, SD=34.2); “effects
of treatment on social and family life” (M=51.4, SD=36.5); and “effects of treatment on sexual
activity” (M=30.0, SD=37.8).
Information about other services. The reported mean need score for the “information
about other services” subscale was 33.1 (SD=29.3), which was comprised of four items. These
items included: “additional help outside the home” (M=30.6, SD=34.9); “rehabilitation services”
(M=27.9, SD=35.7); “aspects of managing illness at home” (M=47.4 SD=36.9); and “possible
professional psychological support” (M=26.0, SD=33.4).
Single items. There were two items that were single items in the information needs scale.
“Different places of care” scored a mean level of information need of 40.4 (SD=38.2) and the
other single item, “things you can do to help yourself get well” had a mean level of information
need of 56.5 (SD=35.1).
Added items. Four items were added to the existing information needs measure. These
included information need for: “the effects of treatment on fertility” (M=13.0, SD= 29.5); “other
treatment options” (M=53.3, SD=40.4); “financial/insurance resources” (M=48.2, SD=39.3); and
“whether family members are at risk” (M= 49.2, SD=40.5).
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Table 4: Information needs
Not at
All

A Little

Quite a Bit

Very
Much

Scaled Score
(0 low – 100
high)
Mean (SD)

Frequency (%)
Disease Subscale
The diagnosis of your cancer (n=111)

4 (3.6)

16 (14.4)

26 (23.4)

65 (58.6)

74.6 (28.3)
79.0 (28.8)

The extent of your cancer (n=110)

9 (8.2)

19 (17.3)

26 (23.6)

56 (50.9)

72.4 (33.1)

The possible causes of your cancer (n=107)

10 (9.3)

31 (29.0)

21 (19.6)

45 (42.1)

64.8 (34.8)

Whether the cancer is under control (n=110)

5 (4.5)

12 (10.9)

21 (19.1)

72 (65.5)

81.8 (28.8)

10 (9.1)

21 (19.1)

33 (30.0)

46 (41.8)

69.7 (28.9)
68.2 (33.0)

9 (8.2)

29 (26.3)

28 (25.5)

44 (40.0)

65.8 (33.3)

The results of the medical tests you have received
(n=110)
Treatment Subscale
The medical treatment (chemotherapy, radiotherapy,
surgery, or other modality) (n=111)
The expected benefit of treatment (n=111)

3 (2.7)

20 (18.2)

32 (29.1)

55 (50.0)

75.5 (28.4)

9 (8.1)

12 (10.8)

27 (24.3)

63 (56.8)

64,8 (26.3)
76.6 (32.0)

7 (6.3)

7 (6.3)

32 (28.8)

65 (58.6)

80.0 (28.9)

The possible side effects of the treatment (n=111)

10 (9.0)

8 (7.2)

35 (31.5)

58 (52.3)

75.7 (31.4)

The expected effects of the treatment on cancer
symptoms (n=109)
The effects of the treatment on social and family life
(n=111)
The effects of treatment on sexual activity (n=108)

13 (11.9)

8 (7.3)

28 (25.7)

60 (55.0)

74.6 (34.2)

24 (21.6)

31 (27.9)

28 (25.2)

28 (25.2)

51.4 (36.5)

57 (52.8)

23 (21.3)

10 (9.3)

18 (16.7)

30.0 (37.8)

Other Services Subscale
Additional help outside the hospital (n=111)

51 (45.9)

32 (28.8)

14 (12.6)

14 (12.6)

33.1 (29.3)
30.6 (34.9)

Rehabilitation services (n=110)

58 (52.7)

27 (24.5)

10 (9.1)

15 (13.6)

27.9 (35.7)

Aspects of managing your illness at home (n=111)

29 (26.1)

31 (27.9)

26 (23.4)

25 (22.5)

47.4 (36.9)

Possible professional psychological support (n=108)

59 (54.6)

25 (23.1)

14 (12.9)

10 (9.3)

26.0 (33.4)

Single Items
Different places of care (n=109)

40 (36.7)

28 (25.7)

19 (17.4)

22 (20.2)

40.4 (38.2)

Things that you can do to help yourself get well
(n=111)
Added Items

16 (14.4)

35 (31.5)

27 (24.3)

33 (29.7)

56.5 (35.1)

The effects of treatment on fertility (n=108)

87 (80.6)

8 (7.4)

5 (4.6)

8 (7.4)

13.0 (29.5)

Other treatment options (n=109)

30 (27.5)

21 (19.3)

21 (19.3)

37 (33.9)

53.3 (40.4)

Financial, insurance, work-related or legal resources
(n=110)

32 (29.1)

27 (24.5)

21 (19.1)

30 (27.3)

48.2 (39.3)

Whether family members at risk for developing
cancer (n=109)

34 (31.2)

21 (19.3)

22 (20.2)

32 (29.4)

49.2 (40.5)

Medical Test Subscale
The purpose of any medical tests you have had
(n=110)
The procedures of the medical tests (n=110)
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Information Received
In addition to information needs, participants were also asked to report the amount of
information they received for each informational item for which they reported information needs.
Below are the mean score results for information received for the four information received
subscales along with scores for each of the items comprising the scale. Table 5 shows each of
the 23 informational received items included in the scale along with respondent frequency and
percentage reporting level of information received on a Likert scale from 1 (not at all) to 4 (very
much). The Likert scale for each subscale and each item was converted into a 100-point scale
called the scaled score. Table 5 also contains the mean scaled scores and standard deviations for
each information received subscale and contains the scaled score and standard deviation for each
information received items. Scores for the subscales and individual items are continuous ranging
from 0 (low level of information received) to a score of 100 (high level of information received).
Information about disease. The mean information received score for the subscale,
“information about disease” was high at 62.1 (SD=26.9). Four items comprise this scale with the
following mean information received scores. The mean level of information received for the item
“diagnosis about your cancer” was 73.6 (SD=27.4); “the extent of your cancer” was 65.2
(SD=35.1); “the possible causes of your cancer” was 42.9 (SD=37.0); and “whether the cancer is
under control” was 66.0 (SD=32.8).
Information about medical tests. Participants’ mean information received score for the
subscale, “information about medical tests” was also high at 72.8 (SD=25.4). Three information
received items comprised this subscale with the following mean level of information need: “the
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purpose of medical tests” (M=71.2, SD=28.7); “the procedures of the medical tests” (M=71.5,
SD=27.0); and “the results of the medical tests” (M=75.8 SD=27.1).
Information about treatment. The mean received score for “information about
treatment” subscale was 59.9 (SD=27.3). This subscale included six items. The mean
information received score for “treatment modality” (M=76.1, SD=28.4); “expected benefit of
treatment” (M=71.5, SD=30.9); “possible side effects of treatment” (M=69.4, SD=34.0);
“expected effects of treatment on symptoms” (M=65.5, SD=34.8); “effects of treatment on social
and family life” (M=47.5, SD=36.2); and “effects of treatment on sexual activity” (M=27.5,
SD=34.7).
Information about other services. The mean for the information received subscale,
“information about other services” was low with a mean reported score of 32.36 (SD=26.892).
Four items comprised this subscale of information received. These items included: “additional
help outside the home” (M=27.6, SD=33.1); “rehabilitation services” (M=28.2, SD=35.0);
“aspects of managing illness at home” (M=50.5, SD=34.2); and “possible professional
psychological support” (M=23.6, SD=29.4).
Single items. There were two items that were single items in the information received
scale. “Different places of care” mean received score was 32.4 (SD=35.1) and the other item,
“things you can do to help yourself get well” was found to have a mean score of information
received of 56.2 (SD=35.9).
Added items. Four items were added to the measure. This included information received
for: “the effects of treatment on fertility” (M=18.2, SD=31.6); “Other treatment options”
(M=38.1, (SD=36.1); “financial/insurance resources” (M=35.8, SD=35.8); and “whether family
members are at risk” was (M=32.4, SD=36.9).
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Table 5: Information received
Not at All

A Little

Quite a Bit

Very
Much

Scaled Score
Mean (SD)

Frequency (%)
Disease Subscale
The diagnosis of your cancer (n=111)

4 (3.6)

16 (14.1)

44 (39.4)

47 (43.3)

62.1 (26.9)
73.6 (27.4)

The extent of your cancer (n=110)

15 (13.6)

18 (16.4)

34 (30.9)

43 (39.1)

65.2 (35.1)

The possible causes of your cancer (n=108)

33 (30.6)

33 (30.6)

20 (18.5)

22 (20.4)

42.9 (37.03)

Whether the cancer is under control (n=104)

10 (9.6)

21 (20.2)

34 (32.7)

39 (37.5)

66.1 (32.8)

5 (4.5)

19 (17.3)

42 (38.2)

44 (40.0)

72.8 (25.4)
71.2 (28.7)

1 (.90)

26 (23.6)

39 (35.5)

44 (40.0)

71.5 (27.0)

2 (1.8)

19 (17.3)

36 (32.7)

53 (48.1)

75.8 (27.1)

5 (4.6)

13 (11.9)

37 (33.9)

54 (49.5)

59.9 (27.3)
76.1 (28.4)

Medical Test Subscale
The purpose of any medical tests you have
had (n=110)
The procedures of the medical tests (n=110)
The results of the medical tests you have
received (n=110)
Medical Treatment Subscale
The medical treatment (chemotherapy,
radiotherapy, surgery, or other modality)
(n=109)
The expected benefit of treatment (n=110)

8 (7.3)

16 (14.5)

38 (34.5)

48 (43.6)

71.5 (30.9)

The possible side effects of the treatment
(n=111)
The expected effects of the treatment on
cancer symptoms (n=112)
The effects of the treatment on social and
family life (n=108)
The effects of treatment on sexual activity
(n=108)
Other Services Subscale
Additional help outside the hospital (n=110)

12 (10.8)

17 (15.3)

32 (28.8)

50 (45.0)

69.4 (34.0)

14 (12.6)

20 (18.0)

33 (29.7)

44 (39.6)

65.5 (34.8)

27 (25.0)

31 (28.7)

27 (25.0)

23 (21.3)

47.5 (36.2)

57 (52.8)

25 (23.1)

14 (13.0)

12 (11.1)

27.5 (34.7)

53 (48.2)

35 (31.8)

10 (9.1)

12 (10.9)

32.3 (26.8)
27.6 (33.1)

Rehabilitation services (n=110)

56 (50.9)

29 (26.4)

11 (10.0)

14 (12.7)

28.2 (35.0)

Aspects of managing your illness at home
(n=111)
Possible professional psychological support
(n=110)

21 (18.9)

35 (31.5)

32 (28.8)

23 (20.7)

50.5 (34.2)

55 (50.0)

40 (36.4)

7 (6.4)

8 (7.3)

23.6 (29.4)

Different places of care (n=112)

50 (44.6)

28 (25.0)

21 (18.8)

13 (11.6)

32.4 (35.1)

Things that you can do to help yourself get
well (n=111)
Added Items

18 (16.2)

33 (29.7)

26 (23.4)

34 (30.6)

56.2 (36.0)

The effects of treatment on fertility (n=106)

73 (68.9)

17 (16.0)

7 (6.6)

9 (8.5)

18.2 (31.6)

Other treatment options (n=106)

37 (34.9)

35 (33.0)

16 (15.1)

18 (17.0)

38.1 (36.1)

Financial, insurance, work-related or legal
resources (n=108)
Whether family members at risk for
developing cancer (n=106)

40 (37.0)

38 (35.2)

12 (11.1)

18 (16.7)

35.8 (35.8)

49 (46.2)

28 (26.4)

12 (11.3)

17 (16.0)

32.4 (36.9)

Single Items
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Unmet Information Needs
Unmet information needs were assessed for information subscales and each of the 23 individual
items.
Information subscales. Unmet information needs (differences in information needs and
information received) were calculated by computing scale scores for information needs and
information received for each of the information needs and information received subscales
(information disease, medical tests, treatment, other services) and the two single items (different
places of care, and things you can do to help yourself get well). Greater mean scores indicate
greater amounts of information needs or greater amounts of information received. The scaled
score means of information received was subtracted from information needs for each information
subscale and for each individual information item. A positive value indicates that information
needs were greater than information received. A negative value indicates a higher amount of
information received than was needed.
Patients reported a high level of information needs for information about disease with a
mean scale score of 74.6, however, reported an information received mean scale score of only
62.1, resulting in a significant difference of 12.4 (p=0.0003). No other information sub-scales
were significantly different between information needs and information received.
Unmet information needs for individual items. In addition to differences in
information subscale scores between information needs and information received, differences in
all 23 individual items of information needs and received were assessed for differences. There
were significant differences in information needs among two information about disease subscale
items where patients reported higher need than information received. Patients reported high
mean need (64.8) for information about possible causes of their cancer, but only reported
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information received at a mean of (42.9), resulting in a significant difference of 21.9 (p<.0001).
Patients also reported an unmet need for information about “whether their cancer is under
control” with a difference of 15.79 (p=0.0306) and the added item, “whether family members are
at risk for developing cancer” with a mean difference of 16.8 (p=0.0016).
Unmet needs were also reported in one treatment subscale item with patients needing
more information than received about “the expected benefit of treatment” (difference=8.3,
p=0.0388). Patients desired more information than received about treatment options
(difference=15.28, p=0.0037) an added treatment-related item. Another added item,
“information about financial, insurance, work-related or legal resources” also had a significant
difference of 12.38 (p=0.0158).
Information Need Differences by Demographics
Chi-square and logistic regression analyses were conducted to assess the demographic
differences in level (high need versus low need) for each of the information need sub-scales and
all 23 information need items. There were differences found in information needs by gender,
race, and age.
Information need scale differences by gender. For the subscale, “information about
disease” there were gender differences in information needs. Ninety-two percent of males
reported high needs, whereas 76.6% of females reported high needs. This resulted in a
significant proportion difference of 15.4 (p=0.0378). There was also a significant difference in
gender information needs in the subscale of “information about medical tests.” Males (84.3%)
reported higher need than females (63.3%). This difference in proportions (20.9) was found to be
significant (χ2=6.153, DF=1, p=0.0131). The only other significant difference in information
needs by gender was “information needs about treatment.” Males (86.2%) reported high needs
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and only 66.6% of females reported high needs resulting in a significant difference of 19.6
(χ2=5.758, DF=1, P=0.0164).
Information need item differences by gender. Gender differences in information need
were seen for the “extent of your cancer (item in the information about disease subscale);”
“purpose of medical tests (item in the information about medical tests subscale)” “expected
effects of treatment on cancer symptoms (item in the treatment subscale);” and “different places
of care (single item).” Forty-three males reported high information needs (86.0%) for the extent
of cancer where 39 females reported high needs (65.0%), with a proportion difference of 21
(95% CI [0.04, 0.35]). Differences in need between males and females were found to be
significant (χ2=6.334 df=1, p=0.0118). Males (82.4%) and females (62.7%) reported high
information needs for the purpose of medical tests, with males reporting a higher proportion
difference of 19.6 (95% CI [0.02, 0.34]) in need which was found to be significant (χ2=5.214
df=1, p=0.0224).
Males had significantly higher levels of need for other items, with 90% of males
reporting high needs for the “expected effects of treatment on cancer symptoms” and 72% of
females reporting high needs for the same item (χ2=5.099, df=1, p-value=0.0239). There was a
21.4 difference in proportions of high needs for “different places of care,” with males having a
significantly higher level of need (χ2=5.313, df=1, p-value=0.0212).
Information need scale differences by race: None of the information scales showed a
significant difference in race (Whites and non-Whites), although there were race differences
between Whites and non-Whites, with Whites reporting less information need than non-Whites
for specific items. For Whites, the mean level of information need for “aspects of managing your
illness at home” was 38.4 and for non-Whites 60.6, with a significant proportion difference of
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22.2 (χ2=4.594 df=1, p=0.0321). For Whites the mean level of need for “effects of treatment on
sexual activity” was 19.7 and for non-Whites 43.7, resulting in a significant proportion
difference of 24.0 (χ2=24.013 df=1, p=0.00101).
Information need scale differences by age: Older age proved significant for higher
levels of information need of the subscale, “information about disease.” The mean age for high
needs for this subscale was 60.7 (SD=14.9, 95% CI [57.63, 63.76]) whereas the mean age for
low needs was 49.4 (SD=18.3, 95% CI [40.27, 58.50]). For every one-unit increase in age, the
odds of having high needs for “information about disease” increase by 0.04 (χ2=7.00, DF=1,
p=0.0082).
Information need item differences by age: Age proved significant for high information
needs for information for two items in the information about disease subscale: “cancer extent;”
and “whether the cancer is under control.” The mean age of high needs (82.0%) was 60.7 years
and for low needs (28.0%) the mean age was 52.9 (SD=14.0, 95% CI [57.64, 63.84]. A one-unit
increase in age increases the odds of having high information needs for “the extent of cancer” by
1.03 (χ2=4.85, df=1, p=0.0277). The mean age of patients reporting high levels of information
need for “whether the cancer is under control” was 60.3 and the mean age reporting low needs is
49.6. The odds of having high information need for this item increase by 1.04 for each unit
increase in age (χ2=6.04 df=1, p=0.0124).
There were also age differences in information needs in three items included in the
“information about medical tests” subscale: the “purpose of the medical tests;” “the procedures
of the medical tests,” and “the results of medical tests.” The mean age reporting high needs for
the purpose of medical tests was 60.7 and the mean age reporting low needs was 53.4. The odds
of having higher needs for the purpose of medical tests was 1.02 greater for each one-unit
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increase in age. (χ2=4.16, p=0.0413). The mean age of patients reporting high levels of
information need for “procedures of the medical tests” was 61.1 and the mean age reporting low
needs was 54.4. The odds of having high information received for this item increase by 1.026
for each unit increase in age (χ2=4.19 df=1, p=0.0405). The mean age of patients reporting high
levels of information need for “results of medical tests” was 61.2 and the mean age reporting low
needs is 49.9. The odds of having high information need for this item increase by 1.04 for each
unit increase in age (χ2=8.20 df=1, p=0.0042).
High information needs also significantly increased with age for the item, “the expected
benefit of treatment” which is an item in the treatment subscale. The mean age of patients
reporting high levels of information need for “expected benefit of treatment” was 60.3 and the
mean age reporting low needs is 48.6. The odds of having high information need for this item
increase by 1.045 for each unit increase in age (χ2=6.15 df=1, p=0.0132).
Information needs significantly decreased with age for “the effects of treatment on
sexual activity (an item included in the treatment subscale),” and “the effects of treatment on
fertility.” The mean age of patients reporting high levels of information need for “the effects of
treatment on sexual activity” was 53.3 and the mean age reporting low needs is 60.3. The odds
of having high information need for this item decrease by 0.972 for each unit increase in age
(χ2=4.01 df=1, p=0.0451). The mean age of patients reporting high levels of information need for
“effects of treatment on fertility” was 40.8 and the mean age reporting low needs is 61.1. The
odds of having high information need for this item decrease by 0.91 for each unit increase in age
(χ2=14.22 df=1, p=0.0002).
Information received differences by demographics. Information received levels
(high/low) were also assessed for each of the information received subscales and all 23
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information received items to assess if information received varied by demographics. Chi-square
and logistic regression analyses showed that information received items varied by the
demographics of gender, race, and age.
Information received scale differences by gender: There were no differences in any subscales by gender, although there were significant item differences in the level of information
received about the “medical treatment modality (an item in the information about treatment
subscale)” between males and females. Ninety-two percent of males reported receiving high
levels of information received about “medical treatment” as compared to only 76.3% of females
reported high levels, resulting in a significant difference of 15.3 in proportions between the two
groups using Fisher’s Exact Test (p=0.0376). There were no other significant differences by item
in this subscale.
Information received scale differences by race: There were no differences in any of the
information received sub-scales by race, however, there were differences in an individual item.
There were differences between information received about “the extent of your cancer” (an item
in the information about disease subscale) between Whites and non-Whites with Whites
reporting receiving more information than non-Whites. Fifty-six percent of non-White
participants reported receiving high levels of information about “the extent of their cancer” as
compared to 76.3% of Whites. This difference of 20.4 in proportions was a significant
difference in information received between the two groups (χ2=4.670, DF=1, p=0.0307). There
were no other significant differences by item in this subscale.
Information received scales by age: There was a significant difference in age for the
information received scale, “information about other services.” The mean age for having high
level of information received for the scale was 51.6 (SD=15.6, 95% CI [45.08, 58.03]) and the
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mean age for low level of information received was 61.1 (SD=15.4, 95% CI [57.77, 64.38]). For
every one-unit increase in age, information received for information about other services
decreases by 0.03 (χ2=6.52, DF=1, p=0.0106).
Information received item differences by age: Information received levels varied by age
for three items. There were lower levels of information received for “effects of treatment on
sexual activity (an item in the information about treatment subscale)” and also the “effects of
treatment on fertility (an added single item).” Information received for both of those items
decrease with older age. The mean age reporting high received for the “effects of treatment on
sexual activity” is 49.2 and the mean age reporting low received is 61.7. The odds of having
received high levels of information about this item decreased by 0.95 for each unit increase in
age (χ2=10.68 DF=1, p=0.0011). Likewise, the odds decrease by 0.95 for each unit increase in
age for the information received about “the effects of treatment on fertility (χ2=7.33, df=1,
p=0.0).
Levels of information received also differed by age for the “other services” subscale item,
“additional help outside the home.” The mean age for high levels received for this item was 60.7
years and for low levels received the mean age was 51.5. Being an older age was significant for
higher levels of information received for this item. For each one-unit increase in age, the odds of
receiving higher levels of information about additional help outside the home increased by 1.04
(χ2=5.52, df=1, p=0.0188)
Information Sources
Sources sought. Participants were asked to select all sources where they seek health
information from a list of 12 various sources. Source types to choose from included: books,
brochures, cancer organizations, friends, doctor, Internet, library, magazines, newspapers,
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telephone information number, and complementary medicine sources. Participants were also
asked to specify whether they sought information from any other sources and, if so, they were
prompted to list them. Out of 112 participants responding to the question, nearly all (93.8%)
reported searching for health information from any source. The most sought source for
information was the Internet (n=89, 80.9%), followed by doctor or health care provider (74.5%).
Over a third of participants (n=43) reported using cancer organizations (39.1%) as a source for
finding information and seeking information and 36.3% reported receiving information from
brochures and pamphlets. The least reported sources of information for health information were
complementary and alternative medicine (3.6%) and telephone information hotlines, with only
two participants (1.8%) reporting using this channel to seek information. A complete list of all
sources participants used to search and the frequency of reported use is found in Table 6.
Sources preferred. Participants were also asked to select one preferred choice of
information from the same list of sources from which they sought information. The majority of
the sample (n=91) reported preferring their “Doctor or health care provider (80.5%)” as a source
for information, followed by Internet (23.0%) and cancer organizations (17.7%). The least
preferred sources for health information were magazines, newspaper, telephone information
numbers, library, and friends/co-workers, with less than 2% of participants preferring each of
these. No participants reported preferring complementary alternative, or unconventional
practitioners as a source of information. Participants’ health information source preference
frequencies and percentages are found in Table 6.
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Table 6: Sources preferred and used for information
Sources
Doctor or health care provider
Internet
Cancer organization
Brochures, pamphlets, etc.
Books
Family
Friend/Co-Worker
Magazines
Other
Library
Newspapers
Telephone information number
Complementary, alternative, or unconventional
practitioner

Preferred Source
(n=113)
Frequency (%)
91 (80.5)
26 (23.0)
20 (17.7)
9 (8.0)
5 (4.4)
3 (2.7)
2 (1.8)
2 (1.8)
2 (1.8)
1 (.89)
1 (.89)
1 (.89)
0 (0.0)

Sources Used
(n=112)
Frequency (%)
82 (74.5)
89 (80.9)
43 (39.1)
40 (36.3)
17 (15.5)
35 (31.8)
28 (25.5)
16 (14.5)
1 (.90)
10 (9.1)
8 (7.3)
2 (1.8)
4 (3.6)

Information Satisfaction
In addition to participants’ information satisfaction, questions assessed perceived helpfulness of
the information they received about their rare cancer. Two questions assessed whether
participants desired additional information and an open-ended question asked what additional
information they desired. Questions also assessed the participants’ self-confidence finding
health information about their condition and their perceived level of difficulty in finding and
receiving the information to fill their information needs. Finally, participants’ trust in the health
information sources was also assessed.
Overall information satisfaction. Participants’ general information satisfaction was
assessed with the question, “Overall, were you satisfied with the information you received about
your rare cancer?” with a yes/no response. While the majority of participants (81.1%) reported
being satisfied with the information they received about their rare cancer, 21 participants
(18.9%) reported dissatisfaction. Even though the majority reported being satisfied with the
information they received, 46 participants (43.0%) reported they desired additional information
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about their conditions, while only 4 participants (4.3%) desired receiving less information.
Information satisfaction data can be found in Table 7 below.
Table 7: Overall information satisfaction
In general, were you satisfied with
the information?
N=111
Did you desire additional
information?
N=107
Did you desire less information?
N=92

Yes
N (%)
90 (81.7)

No
N (%)
21 (18.9)

46 (43.0)

61 (57.0)

4 (4.3)

88 (95.7)

Information satisfaction by demographics. Information satisfaction by demographics
can be found in Table 8 below. Information satisfaction was not found to be significantly
different between race (White/non-White) and was not found to be significantly different due to
age. There was, however, a significant difference between the proportion of males and females
who reported dissatisfaction with the information they received. Ten percent of males were
dissatisfied with information received, whereas 25.8% of females reported dissatisfaction. The
difference in these proportions of 15.6 was found to be significantly different (χ2=4.343, df=1,
P=0.0372).
Table 8: Information satisfaction differences by demographics
Demographic

Information Satisfaction
Satisfied

Dissatisfied

n

Proportion
reporting
dissatisfaction

49
62

10.2
25.8

Gender
Male
Female

44
46

White
Non-White

64
26

5
16

Proportion difference
(95% CI)
-15.60
[-0.28, -0.00]

Chi-Square
DF=1
4.343

P-value
0.0372*

6.66
[-0.09, 0.23]

0.679

0.4099

Race

Age

13
8
N
Satisfied
90
Dissatisfied 21

Parameter Estimates
Term
Estimate
Std. Error
Intercept
-2.1617716
0.994
Age
0.01179059
0.015

77
16.8
34
25.5
mean age (SD)
54.5 (16.3)
61.3 (14.3)

ChiSquare
4.73
0.55

Prob>ChiSq
0.0296
0.4502

79

95% CI [55.02, 61.88]
95% CI [54.81, 67.85]
Odds Ratio 95% CI
1.01186
[0.981, 0.988]

Perceived helpfulness of information. Participants’ perceived helpfulness of the
information they received was also assessed using one question, “How helpful was the
information?” Response categories were on a four-point Likert scale anchored with “not at all”
on one end and “very much” on the other. The majority of the participants (81.5%) responded
with “quite a bit” or “very much” to the question, while only 19 participants reported that the
information they received was not at all helpful (0.9%) or only “a little’ helpful (17.5%).
Perceived helpfulness of information can be found in Table 9 below.
Table 9: Perceived helpfulness of information

How helpful was the information?
N=103

Not at All
N (%)

A Little
N (%)

1 (0.97)

18 (17.5)

Quite a
Bit
N (%)
37 (35.9)

Very Much
N (%)
47 (45.6)

Searching confidence. Participants’ self-confidence in their ability to obtain information
was assessed with the question, “Overall, how confident are you that you could get advice or
information about health or medical topics if you needed it?” Responses were on a five-point
Likert scale anchored on one end with “completely confident” and on the other end, “not
confident at all” and can be found in Table 10 below. Overall, the majority of the sample
reported being confident in finding information about their rare cancer. Thirty-two participants
(28.6%) reported being completely confident and 43 participants (38.4%) reported being very
confident in their ability to obtain health information. Thirty participants (26.8%) reported being
only somewhat confident, five participants reported being only a little confident (5.4%), and one
participant (0.9%) reported being, “not at all” confident in their ability to find health information.
Table 10: Searching confidence

How confident are you that you could
get advice or information? (n=112)

Completely
N (%)

Very
N (%)

Somewhat
N (%)

A Little
N (%0

32 (28.6)

43 (38.4)

30 (26.8)

6 (5.4)
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Not at
All
N (%)
1 (.90)

Amount of effort to find information. The amount of effort perceived to find
information was assessed by having participants respond to how much they agree with, “It took a
lot of effort to get the information you needed.” Responses were on a four-point Likert scale
anchored on one end with “strongly agree” and “strongly disagree” on the other end. Although
the majority of the participants (67.0%) reported having confidence in their ability to obtain
information, 47 participants (44.0%) responded they “strongly agree (17.8%)” or “somewhat
agree (26.2%)” it took a lot of effort to obtain the information they needed.
Level of frustration in finding information. Nearly half (44.4%) of the participants also
reported a level of frustration finding information. Participants were asked to respond on a four
point Likert scale from “strongly agree” to “strongly disagree” to the question “You felt
frustrated during your search for information.” Twenty-one participants reported they “strongly
agree (19.4%)” and 27 participants reported they “somewhat agree (25.0%)” they were frustrated
during their search for the information.
Difficulty understanding information found. Participants reported on a four point
Likert-type scale from strongly agree to strongly disagree to the question, “The information
found was hard to understand” to ascertain participants’ difficulty understanding the information
they received. Although not a majority, nine participants responded they “strongly agreed
(8.3%)” and 34 “somewhat agreed (31.5%)” that the information found was difficult to
understand.
Quality of Information. Participants were asked to report their level of concern about
the quality of information received with the stem question, “You were concerned about the
quality of the information.” Question response format was on a four point Likert scale anchored
by “strongly agree” on one end and “strongly disagree” on the other end. Responses were mostly
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evenly distributed with 27 participants responding, “strongly agree (25.0%)” and 28 participants
responding, “somewhat agree (25.9%).” About half of the respondents reported, “somewhat
disagree (25.0%)” or “strongly disagree (24.1%).” Search effort, frustration with finding
information, understanding of information, and information quality can be found in Table 11
below.
Table 11: Search effort, frustration, understanding, and information quality

It took a lot of effort to get the
information you needed (n=107)
You felt frustrated during your search
for the information (n=108)
The information found was hard to
understand (n=108)
You were concerned about the quality
of the information (n=108)

Strongly
Agree
N (%)
19 (17.8)

Somewhat
Agree
N (%)
28 (26.2)

Somewhat
Disagree
N (%)
36 (33.6)

Strongly
Disagree
N (%)
24 (22.4)

21 (19.4)

27 (25.0)

25 (23.1)

35 (32.4)

9 (8.3)

34 (31.5)

41 (40.0)

24 (22.2)

27 (25.0)

28 (25.9)

27 (25.0)

26 (24.1)

Source Trust. As reported above, approximately 50% of participants were concerned
about the quality of the information they received. Participants were also asked to rate their trust
in sources. Sources they were asked to rate included: doctor, family or friends, newspaper or
magazines, radio, Internet, television, government health agencies, charitable organizations, and
religious organizations and leaders. Participants’ reported trust in sources can be found in Table
12 below. Responses were on a four point Likert-scale anchored by “not at all” on one end and
“a lot” on the other end. More than any other source, participants reported trusting their doctor.
Eighteen participants (15.9%) reported trusting their doctor “some” and 93 participants (82.3%)
reported they trust their doctor as a source of information “a lot.” Following trust of doctors was
participants’ trust in the Internet, with 58 participants reporting “some” (53.2%) trust and 20
reporting, “a lot” (18.4%) of trust. Other reported trusted sources of information are government
health agencies and charitable organizations, with 66 participants reporting “some” (44.5%) or “a
lot” (15.5%) of trust for government agencies and 57 participants reporting “some” (44.5%) or “a
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lot” (7.2%) of trust for charitable organizations. The least trusted sources reported by the sample
were radio, with 91 participants reporting “not at all” (46.2%) or “a little” (40%) trust and
television, with 44 participants (40.7%) responding “a little” and 36 participants (33.3%)
reporting “not at all.”
Table 12: Trust in information sources
Frequency (%)

Not at All

A Little

Some

A Lot

Doctor (n=113)

0 (0.0)

2 (1.8)

18 (15.9)

93 (82.3)

Internet (n=109)

6 (5.5)

25 (22.9)

58 (53.2)

20 (18.4)

Government health
agencies (n=110)
Family or Friends
(n=110)
Charitable
organizations (n=110)
Religious
organizations and
leaders (n=108)
Television (n=108)

17 (15.5)

27 (24.5)

49 (44.5)

17 (15.5)

16 (14.5)

37 (33.6)

48 (43.6)

9 (8.2)

23 (20.9)

30 (27.2)

49 (44.5)

8 (7.2)

38 (35.2)

35 (32.4)

30 (27.8)

5 (4.6)

36 (33.3)

44 (40.7)

27 (25.0)

1 (.92)

Newspaper or
magazines (n=110)
Radio (n=108)

20 (18.2)

49 (44.5)

41 (37.2)

0 (0.0)

50 (46.2)

41 (40.0)

17 (15.7)

0 (0.0)

Health-Related Quality of Life
Health-related quality of life was assessed using the SF-12 and was scored using scoring
software. Scores are norm-based with a norm mean of 50 (SD=10.0) and range from 0 to 100.
Higher scores indicate better health for both the physical health component and the mental health
component, where lower scores indicate worse health for both physical and mental components.
The overall health-related quality of life physical health mean component score for the sample
was M=40.0 (SD=11.6) and the mean mental health component score for the sample was
M=49.6 (SD=9.7). Health-related quality of life scores and information satisfaction can be found
in Table 13 below.
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Information Satisfaction and Health-Related Quality of Life
Two-sided t-tests were used to compare health-related quality of life (physical health component
and mental health component) scores between the information satisfied group and the
information dissatisfied group. The mean physical health component score for the information
satisfied group was M=39.8 (SD=11.7) and the mean physical health component for the
information dissatisfied group was M=41.0 (SD=10.9). A difference of -1.2 (SE=2.8, 95% CI [ 6.93, 4.48] between the two groups was shown not to be significant (t106=0.42485, p=0.6718).
Likewise, the 1.2 difference (SE=2.4, 95% CI [-3.51, 6.10] between the information satisfied and
information dissatisfied groups’ mental component score was found to not be significant
(t106=0.5335, p=0.5948).

Table 13: Information satisfaction and health-related quality of life

Physical
Component
Scale
(0-100)
(PCS)
Mental
Component
Scale
(0-100)
(MCS)

All Participants
HRQL Score
(SD)
n=111
40.091
(11.645)

Information
Satisfied Group
HRQL Score (SD)
n=88
39.894 (11.776)

Information
Dissatisfied Group
HRQL Score (SD)
n=20
41.067
(10.901)

Group
Difference
SE
[95% CI]
-1.223
2.879
[-6.932,
4.485]

t (DF)

p-value

-0.42485
(106)

0.6718

49.69
(9.704)

49.949
(9.700)

48.655
(10.171)

1.293
2.424
[-3.513,
6.100]

0.5335
(106)

0.5948
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Chapter VI. Discussion

Information Needs and Information Received
This study aimed to fill an important gap in the literature by identifying the types of cancerrelated health information that patients diagnosed with rare cancers need in order to improve
information provision to this often over looked population. In addition to identifying the needs of
patients with rare cancers, this study also explored the levels of health information patients
reported receiving. Owing to noted discrepancies in reported information needs and information
received, gaps were subsequently examined to identify unmet needs in this population in order to
gain further insight into ways to meet the information needs of patients with rare cancers.
Information needs. Participants in this study had high needs for most subscales and items
and very high needs were reported for subscales “information about disease,” “information about
medical tests,” and “information about treatment.” Specifically, participants had very high needs
for the individual items, “whether the cancer is under control,” and “the expected benefit of
treatment.” These categories of information, particularly “information about disease” and
“information about treatment” are cancer-specific types of information, which are more difficult
to find and obtain than other subscale information such as “information about other services.”
This is particularly true for rare cancers where there may be very little consumer-level cancerspecific information available. These high reported needs demonstrate the importance for
information provision of cancer specific information to patients with rare cancers. While most
needs were high, participants in this study reported lower need for “information about other
services” and single subscale item, “different places of care.” These reported lower needs may be
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a reflection of where patients are in their health care journey and only a small sub-set of patients
may need access to other services or other places of care. While these needs are reported as low,
health-care providers should still be cognizant of patients who may need access to this type of
information.
Similar to participants with rare cancers in this study, studies of general cancer patients
show that cancer-specific information is reported as a high need. General cancer patients report
desiring to learn more about their specific cancer type including etiology, physical effects,
diagnosis, and symptoms (Rutten et al., 2005). Likewise, general cancer patients also report high
need for treatment-related information including specific cancer treatment and treatment options
(Maddock et al., 2011) similar to the high levels of need found in patients this study of patients
with rare cancers, emphasizing the continued importance of information provision to patients
with general and rare cancers.
Information received. Participants reported high levels of information received for the
subscale “information about medical tests,” and moderately high levels of information received
for “information about disease,” and “information about treatment.” This moderate to high level
of information received reported demonstrates that healthcare providers are delivering high
levels of information and most likely directing patients to other sources of information about
their rare cancer. This also demonstrates that this level of information provision should be
maintained.
Information needs/received by demographics. This study showed that information
needs and information received varied by demographics, specifically by gender, race and age.
There were differences in information needs and information received between males and
females, Whites and non-Whites, and by age. These gender, age, and race differences in
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information needs can inform healthcare providers and information professionals so they can
tailor information for specific demographic groups based upon greater identified need. These
demographic differences can also help inform website development when creating web portals of
information about rare diseases so specific demographic groups can be targeted and provided
with potentially needed types of health information.
Gender. One surprising finding from this study is that men reported having significantly
higher levels of information need for the scales: information about “disease,” “medical tests,”
and “treatment,” and also many information items including the “extent of cancer,” “the purpose
of medical tests,” “expected effects of treatment on symptoms,” and “different places of care.”
This number of differences demonstrates that in some circumstances males have higher
information needs. This finding was so surprising that the researcher verified that the coding of
gender of participants had not been inadvertently switched anywhere throughout the process.
The research literature of the information needs of general cancer patients demonstrates
information needs vary by gender, with females reporting higher levels of information need than
men (Rutten, 2005, 2006). Females also report needing general cancer site information and
psychological support at a higher level than men, whereas men report higher treatment
information needs (Rutten, 2006). The findings of this study conflict with gender differences of
information need found in studies of general cancer patients.
Not only do females report higher levels of information need for cancer information,
research studies show that females are more likely to have higher information need in other noncancer areas of health (Tong, Raynor, & Asiani, 2014; Ek, 2013; and Manierre, 2015). Very few
studies have been conducted to assess the reasons gender based discrepancies exist in health
information needs. Few theories exist that may explain gender differences but one theory is
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gendered perceived risk of illness (Manierre, 2015). If men do not perceive a high risk or threat
from their condition, they may not be motivated to seek information. Men diagnosed with rare
cancers, as in the case of this study, may have a higher perceived risk due to the fact that their
cancer is considered rare. One concept in Johnson’s Comprehensive Model of Cancer
Information Seeking is perceived risk and increased perceived risk is a motivational factor of
searching for information.
For healthcare information provision, this finding of higher information need among
males is important. Healthcare providers and information professionals may need to be
cognizant that with rare cancers, males may desire more information. Given the fact that this
finding of greater information needs for males is very different from other research on general
cancers, more research on the information needs of patients with rare cancers should be
investigated. Interestingly, although men in this study reported higher information needs, females
actually reported a higher level of dissatisfaction with information provision than did males in
this study which should also be further explored in future studies.
Men reported higher need for many information items, however, there was only one item
where males received higher levels of information. Specifically, males reported receiving more
information about “medical treatment” than females.
Race. This study found that Whites and non-Whites in this population largely needed and
received the same levels of information for most information items, however, there are
differences in needs for two information need items and one received item. Non-Whites have
greater information needs for “aspects of managing your illness at home” and “effects of
treatment on sexual activity.” Whites reported receiving more information than non-Whites for
only one item, “the extent of your cancer.”
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Likewise, a study by Asare, Peppone, Roscoe, et al (2016) of patients diagnosed with
general cancers found there were information need differences between Whites and Blacks.
Blacks reported needing significantly more information about cancer tests, follow-up, healthy
living, stress management, and handling stigma.
Being cognizant of these differences of information need by race can help healthcare
professionals be more proactive in providing information. The information need differences
between race found in this study allow providers to target specific racial groups with tailored
health information that will meet their identified information needs.
Age. The research literature also shows there are age differences in information needs,
with older individuals reporting higher needs for information about treatment and younger
individuals most likely to report higher needs for information about general cancer (Rutten,
2006). Rutten (2006) examined informational needs of cancer patients who actively seek cancer
information by socio-demographic status using 2003 HINTS survey data and found that younger
cancer patients were more likely to seek health information than those who are sixty-five or
older.
This study also found significant age differences in information need items. The
likelihood of reporting high needs for, “whether the cancer is under control, “the procedures of
the medical tests,” “the results of the medical tests,” and “expected benefit of treatment”
increased with age. This study found that younger age was significant for higher needs about
“effects of treatment on sexual activity,” and “the effects of treatment on sexual activity.” Also,
younger participants in the study reported receiving this information at higher levels than older
participants. The likelihood of reporting high needs for the subscale “information about other
services” and the “information about other services” subscale item, “additional help outside the
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home” increased with age. Being aware of information differences in needs and received for
patients with rare cancers can help providers tailor information for younger and older patients so
that needs can be met for all age groups.
Participants in this study of all demographics (gender, race, and age) report high levels of
need and received information, however, a minority of the participants report being dissatisfied
with the information they received. This prompted the researcher to explore where there were
unmet needs. Identifying unmet needs provides additional information where information
provision should be increased.
Unmet Information Needs
Although analyzing unmet information needs was not part of the research aims of this study, the
findings are intriguing. The unmet needs found in this study provide clarification regarding how
provision of information to patients with rare cancers should be improved. Examining the unmet
needs found in this study (information need scores greater than information received scores) for
the information sub scales, the largest and statistically significant unmet need was found in
“information about the disease.” This unmet information need is not surprising in the population
of patients diagnosed with rare cancers. The literature shows that patients with rare diseases and
general cancers often express specific disease information as an important need, but report it is
often unmet. For example, Anderson et al. (2013) reported that patients with rare diseases were
dissatisfied with their diagnosis experience. One of the reasons they reported dissatisfaction was
that they did not receive adequate information about their specific rare disease. A study
conducted by Shea-Budgell, Kosarus, Myhill, & Hagan (2014) about information needs of
patients with general cancers found that 43% reported searching for information on their specific
cancer type.
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All other information needs and received scale comparisons were not shown to be
statistically significant for unmet needs. This may be due to the fact that more information is
available about each of these information types because most would be the same types of
information given to patients diagnosed with general cancers. For example, information about
different places of care, other services, and things you can do to help yourself get well may be
easier to obtain because they are general and not disease-specific informational items.
Disease information items: Participants in this study of patients with rare cancers
reported unmet needs in two particular disease information items. Patients reported high
information needs for etiology (possible causes of their cancer) and whether the cancer is under
control. Given that little is known about many rare cancers, cancer etiology may not be known or
may be very difficult information to locate. For example, one rare cancer, Multicentric
Castleman Disease has no known cause. While there are many recent theories as to the etiology
of the disease, currently it is unknown. Patients or their healthcare providers would have to
search the current medical literature to assess the current theories of the etiology of Castleman
Disease and for any other rare cancers where etiology is unknown.
Treatment information items: Two treatment need items were shown to be unmet in
this study: “other treatment options (an added item),” and “the expected benefit of treatment.”
Treatment information has been found to be very important among patients diagnosed with
general cancers. Treatment information was reported as the most important type of information,
more than any other information need in a study by Shea-Budgell, et al. (2014).
In addition to desiring information about specific treatment options offered by their own
physician, patients also desire information about all treatment options available for their
conditions (Castleton, Fong, Wang-Gillam, Waqar, & Jeffe, 2010). Many rare cancers have few
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treatment options available. This may be one reason why patients may experience difficulty
finding treatment information about specific rare diseases. Likewise, there may be a lack of
knowledge regarding treatment options among many oncologists who do not see many patients
with any particular type of rare cancer, especially very rare cancers. Treatment option
information may also be difficult to find if treatments are very new and may only be found in the
latest medical literature.
Likewise, the “expected benefit of treatment” may not be fully known, particularly for
many rare cancers. These cancers often do not have specific United States Food and Drug
Administration (FDA) approved treatments and off-label treatments may be used to treat a rare
cancer. For example, oncologists may treat a rare cancer with a drug that is approved for use in
another related type of cancer, basing treatment options on a few case studies found in the
research literature. There is little research showing expected outcomes of treatment with these
drugs for the particular rare cancer because no randomized controlled trials have been conducted
for many rare cancers. Benefits may be largely unknown resulting in patients having unmet
needs about the benefits of treatment.
Financial, insurance, work-related, and legal resources information item: The only
other statistically significant item where an unmet information need was found was the added
item regarding financial, insurance, work-related, or legal resources information needs.
Interestingly, this was the only item of information need found to be significantly unmet that
would be considered not applicable to a specific cancer. For example, this type of information
can be answered with general informational resources. Though reported needs for this item were
at a moderate level, information received was reported as very low compared to need.
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Financial, insurance, work-related, and legal resources information may be particularly
important for the rare/genetic disease population due to many significant barriers throughout
their healthcare journey (Schaefer, 2012) which may lead to greater financial burden, insurance,
and work-related issues. These patients may require more tests to diagnose their condition, need
to travel long-distances to an oncologist who specializes in their condition, or face battles with
insurance companies over treatments that are not covered because they are considered
experimental or off-label for a rare cancer. This may result in greater financial burden and loss of
time away from work if, for example, patients have to take off more time to travel for tests and to
see specialists and have to pay more money out of pocket. Additionally, patients living with rare
diseases/cancers experience work-place and health insurance discrimination (Williams, 2014).
This unmet information need is an important consideration as it can be addressed. For
example, patients can be referred to social workers or free legal assistance centers that can
address issues related to finances, insurances, and work. Public and consumer health libraries can
also direct patients to information about financial, insurance, legal, and work-related resources as
there are many online resources that address these information needs. By recognizing this as an
information need in this population, an emphasis on disseminating this information should be
made a priority to ensure patients with rare cancers have easy access to financial, insurance,
legal, and work-related information resources.
Information Sources
Source preference and trust: While the majority of participants (80.9%) reported
seeking information from the Internet, only 23% reported this as a source they preferred.
Participants reported a preference for receiving information from their healthcare provider over
all other sources; however, in contrast to their stated preference, reported using the Internet over
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all other sources. While sources used least were also reported as preferred least, patients may not
be receiving sufficient information or they may perceive they are not receiving a sufficient
amount of information from their preferred source, their healthcare provider. This may be
difficult to ascertain given some patients may believe there is more information to access than is
available and some may desire to know everything about their rare cancer.
Furthermore, participants reported they trust their healthcare providers more than any
other source including the Internet. The responses from this study demonstrate that patients are
seeking information from the Internet, which is not their preferred source of information but is
also not as trusted as health care providers a source for information about their rare cancers.
This discrepancy in source preference and trust is concerning; however, it is not
unexpected. Responses of the patients in this study are similar with regards to source preference
and trust of sources in studies of patients diagnosed with general cancers. Those with general
cancers report trusting their healthcare providers more than any other source, but also report
predominantly using the Internet. Studies of general cancer patients show that patients trust their
doctor or healthcare provider as the most trusted source of all sources including the Internet,
family friends, radio, newspaper, or television (Shea-Budgell et al 2014; Halkett et al. 2012). A
secondary data analysis of HINTS survey data found that 38% of cancer patients reported
seeking information from the Internet, more than any other source (Roach et al., 2009).
A study that aimed to answer why patients use the Internet as a source of information
over their healthcare providers found that the healthcare provider’s empathy and amount of time
spent with the patient affect whether patients use the Internet substantially more as a source for
finding health information (Tustin, 2010). Owing to the complexities of many rare diseases,
including rare cancers, physicians may not have the time to adequately address all information

94

needs that patients with rare cancers may have. If patients perceive that their information needs
have not been adequately addressed, patients then may seek the Internet to fill their unmet needs.
Also, due to a lack of specialist physicians for many different rare cancers, particularly
those that are very rare, there may be few physicians with knowledge of the specific rare cancer.
(Spring, 2014b). Healthcare providers may have to search the literature to obtain an adequate
level of information but for many rare cancers may also experience difficulty finding information
about the condition due to the paucity of information. They may also not have the expert
searching skills to find information that may be available and may also need to turn to other
sources, such as physicians, government rare disease organizations, or a health sciences librarian.
With very rare cancers, there simply may not be much at all known about them to find any
substantive information in the consumer health or even the medical literature.
Issues with patients searching the Internet. There are negative implications for patients
not receiving information from their preferred source and then searching for information from
the Internet. Studies show that patients make medical decisions based upon information they find
on the Internet. Patients have been found to decline medical advice from qualified healthcare
professionals, instead following the advice of information they found online. Patients report
making decisions about their own or a loved one’s health based upon information they found
online (Weaver, 2009; Fox, 2002). One study found that 11% of patients refused to follow the
advice or discontinued their physician’s recommended treatment based upon information found
online (Weaver, 2009). In another study, 68% of patients seeking online information reported the
Internet had some impact on healthcare decisions and 16% reported the Internet had a major
impact on healthcare decisions (Fox, 2002).
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Reliable information provision for patients with rare cancers is crucial, particularly since
some of these patients are utilizing Internet health websites and may potentially make decisions
about their health based on this uncertain information. It is imperative that those with rare
cancers be provided with access to health information portals containing high quality, accurate
and credible sources of information. Patients who search the Web via online search engines may
be unaware how to evaluate critically health information sources for accuracy and reliability and
may thus be making decisions based on unreliable or inaccurate information.
Information Satisfaction
Though the majority of participants reported being satisfied with the information they
received about their cancer, they reported frustration with finding and comprehending it. This
may reflect the lack of consumer health information available online about many rare diseases
including rare cancers. There are few authoritative consumer-level rare disease/rare cancer
websites available and are difficult to locate without sophisticated searching skills. Patients may
be overlooking these and other reliable sources of additional information about their cancers. For
example, most participants in the study did not prefer or report using libraries, print resources,
cancer organizations, videos, or interpersonal (communication with other patients) as sources of
information. Patients may benefit from using the help of trained health science librarians to
access consumer level websites about rare conditions. Most information available by doing a
simple Google search of a rare disease are links to medical journal articles aimed at healthcare
providers. These articles are written at a very high reading level, containing complicated
medical jargon, which makes it very difficult for the lay-person to understand. This may have
reflected the high level of reported difficulty understanding information among patients in the
study.
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Furthermore, as discussed earlier, information from the Internet may contain inaccurate,
biased, or even nefarious health information. The possible dangers of navigating the Internet can
be ameliorated through the use of expert search services. For example, a consumer health cancer
library that provides information about complicated medical issues, current therapies, and rare
cancer types and subtypes reports benefits of their expert search service’s impact to its users
(Volk, 2007). Volk (2007) found 96.2% of users of the service reported “some or all”
information that they received through the expert searching service was not provided to them
through any other informational sources (Volk, 2007) demonstrating the importance and benefit
of expert searching for rare cancer information.
In addition to overlooking libraries as a potential source of finding information, few
reported using cancer organizations as a source for information. Cancer organizations can be an
excellent source of finding additional information about specific rare cancers. Many cancer
organizations contain general cancer information but also contain information about specific
cancers or can provide links to or contact information for disease-specific information and can
also often provide disease specific brochures and pamphlets which are particularly helpful for
those patients who do not prefer using the Internet. These organizations not only provide disease
information but also often provide users with support group information and places to connect
with other patients who share similar medical issues providing a source for interpersonal
information about rare cancers. Patients with rare cancers can meet, communicate with, and
learn from others who are experiencing similar medical issues.
Like general cancers, patients with rare cancers do not report using videos as a source of
information. The low reported usage of video may be due to the lack of authoritative consumeroriented online cancer videos and difficulty obtaining DVD cancer videos. Even if located,
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DVDs can often be cost prohibitive for patients. Videos are often an important resource for lowliteracy patients and having access to consumer level authoritative videos may be beneficial to
those patients who have lower literacy or who prefer learning through audio-visual resources.
Despite participants reporting unmet needs, feeling that it took a lot of effort to find
information, and feeling that the information was difficult to understand, the majority of the
participants in this study of patients with rare cancers reported information satisfaction. The
number who reported being unsatisfied with information is roughly equal to other research of
satisfaction with general cancer information. For example, Davies et al. (2008) report that 16%
of patients diagnosed with breast or prostate cancer report that they were dissatisfied with the
information they received about their cancers. A recent study showed that 34% of prostate cancer
patients were dissatisfied with the information they received about their cancer, which was at a
slightly greater level of dissatisfaction than what was found in this study of rare cancer patients
(18.9%) (Lamers, Cuypers, Hunson, de Vries, & Kil, et. al, 2015). Even though these results are
similar to patients diagnosed with general cancers, it was expected that the satisfaction with
information would have been less in the rare cancer population than those diagnosed with more
general types of cancers due to decreased information availability and difficulty finding
information. One hypothesis about this is that participants in this study may have reported
satisfaction because they were satisfied with the care they received by their oncologist and
healthcare team. Due to the satisfaction of participants at the Massey Cancer Center, it may be
beneficial to conduct a study of patients at other institutions to ascertain if patients with rare
cancers are generally satisfied with information provision or whether information satisfaction
may be an anomaly due to the fact that patients at the Massey Cancer Center are receiving
adequate levels of health information from their healthcare providers.
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Information satisfaction by demographics. Though men in this study reported higher
information needs as discussed above, females actually reported a higher level of dissatisfaction
with information provision than did males. This is also an important finding in this study as it
shows that even though only 18.9% of the participants in this study are dissatisfied with the
information they have received, the majority of those dissatisfied with information are females.
Further research is needed to explore reasons why patients are dissatisfied with information,
particularly females, so that information dissatisfaction can be addressed in the rare cancer
patient population.
Health-Related Quality of Life
The research literature shows that unmet needs and low satisfaction with health information can
be associated with negative health outcomes including reduced satisfaction with care, trust in
physician, and health-related quality of life (Husson Mols, & Van de Poll-Franse, 2011). A
recent study of prostate cancer patients focusing on information provision and quality of life
found that approximately 33% of the patients in the study were dissatisfied with health
information provision and those patients had a significantly worse health-related quality of life
than those who were satisfied with information received (Lamers et al, 2015).
Surprisingly, this study of patients with rare cancers conflicts with findings in the
literature and showed no significant difference between health-related quality of life between
those patients who reported information satisfaction and those reporting information
dissatisfaction. One possible reason may be due to the fact that only 18.9% of the participants in
this study reported information dissatisfaction which is a low percentage of those who are
dissatisfied. Lamers et. al (2015) study was a larger sample size including 999 patients with a
response rate that produced a sample size of 697 participants. Of those participating, 222 (32%)
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participants reported being dissatisfied with the information they received about prostate cancer.
Perhaps information satisfaction and health-related quality of life should be examined in a
subsequent study of information needs in a larger sample size of patients to identify if there is a
correlation between information satisfaction and health-related quality of life among patients
diagnosed with rare cancers. Another hypothesis of the reason for the discrepancy between this
study and other studies regarding the relationship between information satisfaction and healthrelated quality of life is that given the six-month time delay in obtaining eligible patients for this
study, patients with lower health-related quality of life may have been deceased by the time they
received the survey or may have been too ill to respond. It is possible the responders were those
who had a higher health-related quality of life compared to non-responders.
Study Impact
Traditionally, the rare disease/rare cancer community has been ignored and there is a general
lack of knowledge about many individual rare cancers, resulting in many challenges for patients
including the challenge of finding information about their condition. This long-standing neglect
by the research community of the rare disease population has led to the growing trend of patient
engagement in their own care and a sense of patient empowerment in the rare disease/rare cancer
patient community (Ayme, Kole, & Groft, 2008). The World Health Organization defines
empowerment as, “a process through which people gain greater control over decisions and
actions affecting their health (1998).” On an individual level, through learning everything they
can about their particular disease, patients with rare diseases become patient experts about their
specific conditions (Ayme, Kole, & Groft, 2008; Spring, 2014a&b).
Patient empowerment also expands the concept of the engaged individual patient level to
the greater rare disease community level. The web has created the opportunity for establishing
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rare disease/cancer online organizations and support groups where people with similar diseases
can meet and discuss their shared experiences. These organizations also present opportunities to
build collaborative relationships with physicians to create online information portals that contain
patient-level information that address the information needs of the rare cancer community.
Overall, the identified information needs and unmet needs identified in this study show
the importance of information provision, particularly disease-specific and treatment information
to patients with rare cancers. Information provision and access to reliable information is
important for this population. In an effort to provide additional information patients can be
encouraged to use other reliable sources to find additional information about their rare cancer if
they are interested in more information.
One easy and cost-effective way of promoting additional sources is via information
prescriptions. The National Institutes of Health and the National Library of Medicine sponsor
the Information Rx project (www.informationrx.org). Information Rx provides free customizable
prescription pads that can be used to direct patients to rare disease information portals,
government agencies, directories for rare disease organizations and nearby libraries. Healthcare
providers are encouraged to write the name and stage of the cancer on the prescription so patients
have the correct cancer name/spelling when searching for information. This also lessens the
burden of the patient so that he/she does not have to remember the name of the cancer or how to
spell it when searching online or when seeking information from other information sources.
Because patients report using the Internet as a source of information over all other
sources, patients should be directed by healthcare providers to websites that contain authoritative
and accurate health information. Information prescriptions can also be used to provide the patient
with pathfinders to reliable online resources. As described above, a Google search may yield
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results containing information that is written at a very high reading level, and may even contain
bias or untrue information and patients may not critically evaluate informational sources before
using them to make health care decisions. While there is little information about rare cancers
online, there are several portals of health information available that contain reliable information
about many rare cancers. Patients should be directed to these portals.
Given the findings of this study that patients with rare cancers report needing information
about their diagnosis and treatment over all other information types, providing patients with this
information is important. Future efforts of rare disease organizations should focus on providing
patients with basic information about rare cancers, with an emphasis on diagnosis information
and treatment. The National Institute of Health’s Genetic and Rare Disease Information Center
(https://rarediseases.info.nih.gov/GARD/) provides a list of rare diseases including a section with
links to many rare cancers. The site provides very limited information about many rare cancers;
however, this may be an excellent starting point for developing more consumer health
information content about rare cancers with a focus on diagnosis and treatment information.
Study Limitations
Study limitations are outlined below with efforts used to ameliorate their effects on the study.
Additionally, recommendations regarding how this study could be improved are included.
Nomenclature. A few participants reacted negatively to the word “rare” that was listed
on the survey and in all letters informing the patients that the study explored the cancer
information needs of patients diagnosed with rare cancers. These individuals were unaware that
their cancer is considered rare or thought “rare” is an actual type of cancer. Using the word
“uncommon” or the phrase “not commonly occurring” may have been a better choice of
terminology and would not have elicited a negative response from patients. Most patients,
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however, were keenly aware they had been diagnosed with a rare cancer and expressed their
appreciation that this study focused on patients with rare cancers.
Six-month embargo on cancer registry list. The Massey Cancer Center cancer registry
was used to identify patients eligible for participation in the study. The registry list, however, is
on a six-month time delay meaning that patients are not listed in the registry until six months’
post diagnosis. As a result of this delay in identifying eligible patients, several patients died
prior to or after receiving the letter. Six patients were reported as having died by their spouse or
other family member. It is also possible that many patients who did not respond to the survey
were gravely ill or had recently died given the time from diagnosis to survey contact.
Generalizability of the study. This study may or may not be generalizable to other
settings; however, since this study takes place at an academic safety net medical center, it may be
representative of other similar safety net academic medical centers and generalizable to those
centers.
Absence of level of education data. Originally, the researcher intended to collect data on
cancer health literacy using the CHLT-6, however the CHLT-6 had not been validated for use in
written surveys. The CHLT-6 was removed from the survey and the question regarding highest
level of education was inadvertently left out in error. Education level is acknowledged to be an
important factor in health information needs and should be addressed in future studies of patients
with rare cancers’ information needs.
Method limitations. This study used a cross-sectional design. While there are many
advantages to using a cross sectional design such as ease of study design, relatively low cost, and
no concerns about the possibility of attrition, there are some disadvantages. One important
limitation is that cross-sectional studies allow only an examination of one-time point. Results
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may have varied if the patient had received the survey at a different time-point in their healthcare
journey. Also, because we examined patients that were diagnosed within the past year, different
patients were at varying stages in their healthcare journey. For example, some patients may have
finished treatment, whereas others were still undergoing treatment. This is especially important
regarding questions related to health-related quality of life. Patients who had finished treatment
and were in remission may have felt better, thus, experiencing a higher health-related quality of
life than patients who were still undergoing chemotherapy or some other treatment.
Additionally, cross-sectional design studies do not allow for making causal inferences so
this study only examined relationships between variables. As such this study did not attempt to
make any type of causal inference between any of the variables included in this study.
Survey instruments. This study utilized the SF-12v.1 to measure patients’ health-related
quality of life. At the time of study conception there were many versions of this instrument
available online. Some contained different response options for the question about physical or
emotional health interfering with social activities. This researcher obtained the survey initially
through the organization that developed the measure for the Patient Reported Outcomes study.
Subsequently, the rights to the SF12 were obtained by Optum and this researcher obtained
approval from Optum to use the measure. Optum, does not recognize a previous response option
“A good bit of the time” and no longer allows for scoring of this response option with their
scoring software. Additionally, in order to ensure validity of the measure, Optum does not allow
for any formatting changes of the measure. Because this measure was included in a survey
booklet with other measures (following the Dillman Tailored Design Method), formatting of the
SF-12 was changed to align with the formatting of the survey booklet to ensure patient ease in
following instructions and completing questions. A brief description of the measure was added
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before the survey questions, questions were renumbered to align with sequencing of all questions
in the survey booklet and minor changes were added to wording to allow for patients to follow
instructions of the questionnaire easily. Optum made an exception to their formatting rules since
the content remained the same and licensed it to Virginia Commonwealth University for this
study. (License # QN035780).
Additionally, minor changes were made to the EORTC questionnaire. The EORTC
instrument is a reliable and validated instrument that measures information received. In addition
to measuring information received, questions about different types of information found in the
EORTC information received measure were also reworded to measure information needs. This
allowed us to 1.) measure information needs since there were no other measures that adequately
measured various types of information needs that we desired to measure in this study, and 2.)
allowed for a direct comparison of information needs and received information. Because the
modified EORTC questions used to measure information needs in this study have not been
validated to measure needs, a limitation exists in using this to measure information needs.
Mailed survey limitations. There are benefits and limitations to using written mailed
surveys. First, mailed survey are only received by patients with a permanent mailing address,
resulting in possible selection bias. Additionally, there is no way of ensuring that only the actual
patient completes the survey. The participant’s spouse, parent, or adult child may have
completed and returned the survey for the patient without our knowledge. Also, without
assistance and guidance which is possible with in-person or telephone surveys, patients may skip
questions, check multiple boxes, not follow the survey directions, or accidentally skip large
sections of the survey. Missing data is a limitation of mailed surveys since participants may
either accidentally skip sections or may decide not to answer certain questions.
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Measurement error is another consideration in mailed surveys (Dillman, 1991).
Participants may intentionally or unintentionally be unable to provide accurate information in
response to the survey. Also, unlike having the questions read to them in a telephone or in-person
survey, mailed surveys require a high level of literacy to read and complete. Low literacy may
result in measurement error if the patient is unable to understand the questions.
Even though there were limitations of the mailed survey there are also many advantages
to using a mailed survey method. The promised 80% response rate of the tailored design method
of mailed surveys is a benefit to using mailed surveys. This study achieved only a 53.2%
response rate; however, this population was comprised of patients who have been diagnosed with
rare cancers that have high associated morbidity and mortality rates. Lack of response may be
due the result of some participants being too ill to participate. Because there was a six-month
delay receiving the patient list from the cancer registry, patients were six to twelve months’ postdiagnosis and their health status could have been adversely compromised by the time the surveys
were mailed. As noted, six (3.0%) patients’ family members called to inform us that the patient
had recently passed away.
Importantly, mailed surveys are also much faster for participants to complete and are less
burdensome than other methods such as telephone surveys, an advantage when working with
patients who may be ill. Participants can begin and complete the surveys on their own time and
pace. Although a potential limitation for the study, an advantage of mailed surveys to
participants is that those who do not wish to participate do not have the additional burden of
declining participation directly and can simply not return the survey.
Receiving mail. Patients were asked to return the mailed surveys in a self-addressed
stamped envelope containing the researcher’s mailing address at the university. Because the
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mail schedule was unpredictable, receiving in batches every six to eight weeks following the
tailored design method frequency of mailing letters was difficult. The mailing schedule for the
fourth letter containing an identical survey, in case the original was lost, was supposed to be sent
two weeks following the third letter. Participants who had previously completed and returned the
survey were also sent a second survey due to the mail delay. A small number of participants
(n=3) completed the second identical survey and returned it, thus resulting in multiple surveys
received from the same participants. For duplicates, one survey from each participant was
randomly selected for inclusion in the study. To correct for potential duplications and to lessen
the burden on participants so they did not feel obligated to complete two identical surveys, the
researcher delayed sending the fourth letter until after approximately 50% of that groups’
surveys had been returned. The mail delivery issues noted above may have affected the overall
response rate. Had mail delivery been timely, the study may have achieved a higher response rate
as demonstrated by other studies using the Dillman method. In future studies, a dedicated postal
box should be used to ensure mail is received in a timely manner.
Study Strengths
Overall, it is recognized the limitations outlined above exist, however, they are outweighed by
the many strengths and benefits of this study.
Fills a needed gap in the literature. Most importantly, this is the first study to examine
the information needs and sources of the rare cancer patient population. The results from this
study contribute to the rare cancer information needs and sources literature, filling an important
gap in the literature.
Ameliorates gap in knowledge. The information from this study about information
needs and sources in this traditionally overlooked population is beneficial so that patients’
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information needs can be addressed and needs can be met. The results from this study provide
healthcare providers with important information regarding needs which are most important to
patients with rare cancers and identifies the areas where there are unmet needs. With these unmet
needs identified, pertinent resources can be made available to patients.
Study location. This study was conducted at a large academic medical center, which is a
safety net hospital serving a diverse population. This provided the opportunity for a diverse
population of patients to participate in the study.
Validated measures. Another strength of the study is that validated measures were used
to assess information needs/received, information sources, and health-related quality of life.
Rare cancer list. There are few lists available of cancers that are considered rare to use
as a guide to identify which cancers are considered rare. This study uses cancers listed in the
Textbook of Uncommon Cancers and selected cancers from the Office of Rare Disease Research
(ORDR) rare cancer list. The researcher consulted with a medical oncologist and the editor of the
Textbook of Uncommon Cancers to create the list. The resulting list is a very thorough
delineation of cancers that are considered rare in the United States.
Future Studies
This study filled a much needed gap in the study of information needs and sources of patients
with rare cancers, however, there is much more to learn regarding the informational needs and
sources of this population. While the cancers used to identify eligible rare cancers in this study
were all considered rare, a next step may be to examine the differences between the needs of
those in this study who had the rarest cancers seen at the study site compared to those whose rare
cancers are more commonly seen there. Based upon the results, it may also be beneficial to
conduct a similar study with exclusively rarer cancers that are not commonly seen at the Massey
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Cancer Center. Due to information satisfaction at the Massey Cancer Center, another next study
may need to be conducted at other sites to assess information needs of this population and
ascertain health information satisfaction in the rare cancer population.
Additionally, a comparison of information needs of patients with rare cancers with those
diagnosed with general/common cancers would also be important to ascertain the differences in
information needs, sources, and information satisfaction between those diagnosed with general
cancers and those diagnosed with rare cancers.
This study also did not examine where patients were on the cancer care continuum since
these patients were at different stages along the healthcare continuum. It would be beneficial to
conduct a longitudinal study of the information needs and sources of patients with rare cancers
throughout the cancer care continuum to ascertain the needs of patients throughout their cancer
care journey.
A future project based upon the results of the information needs of patients would be the
development of a government-sponsored rare cancer information portal. As discussed earlier, a
rare cancer information portal aimed specifically at meeting the information needs of patients
with rare cancers would be especially beneficial for providing reliable and accurate information
to patients and fill a much needed information gap. This resource would benefit patients who
want to learn more about their cancers. Additionally, it would contribute to the building of
information services for the rare cancer community and would enable and empower patients by
providing them information to become patient experts about their rare condition.
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VII. Conclusion

This cross-sectional study examined the information needs and sources used by patients
who have been diagnosed with rare cancers. As detailed above, patients with rare cancers
experience many challenges during their health care journey, including difficulty finding
authoritative information to satisfy their information needs.
As described above, the rare cancer population has traditionally been ignored by the
research community and very little has been written describing the unique information needs and
sources of patients with rare cancers. Most of the literature regarding information needs focuses
on patients with general cancers (non-rare) or on the parents of children with rare genetic
diseases. Additionally, most of the existing studies published on the information needs of rare
diseases are small qualitative studies of patients in European countries.
Overall, this study fills a critical gap in the rare cancer literature by identifying patients’
information needs and sources. This study demonstrates that there are many unmet needs,
particularly in the provision of disease-specific information, treatment, and treatment options.
The patients in this study reported they are not receiving information from their preferred source,
healthcare providers, and are turning to the Internet for information even though they do not
report high levels of trust for this source. Even though the majority of patients in the study were
satisfied overall with the information they received, nearly 20% were not satisfied. Almost all
patients reported desiring more information. Additionally, many reported that it took effort to
find, were frustrated with their searches, found that the information was difficult to understand,
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and were concerned about the quality. Even though there are government organizations created
to address the informational needs of patients with rare cancers, these results show that much
more needs to be for this traditionally underserved population.
Perhaps, with a better understanding of rare cancer patients’ information needs and
sources of information, improvements can be made in the provision of authoritative information
at the health care level and development of improved online information portals. Improved
information provision may, in turn, improve rare cancer patients’ efforts to become empowered
patients and enable them to become patient experts about their particular rare cancers. Effective
information provision can lead to increased met needs and satisfaction which may also have a
positive effect on patient outcomes such as improved health-related quality of life.
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Health Information
Needs of Patients
with Rare Cancers
A study of the information needs and information sources
of patients diagnosed with rare cancers

Department of Social and Behavioral Health
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Thank you for taking the time to complete this
survey about your health information needs. We
appreciate your help.
Your responses are voluntary and will be kept confidential. By completing and
returning the survey you are consenting to participate in this research study.

If you have any questions about this study, please contact Dana Ladd
by telephone at 804-628-2429 or by email at dlladd@vcu.edu.
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Health Information Needs
These are some questions about the different types of information you may have needed about
your cancer or treatment. For each type of information, check the box to show how much
information you needed.
Q1. During your current disease or treatment, did you need information on…
Not at
A Little Quite a
Very
all
Bit
Much
1. The diagnosis of your cancer?




2. The extent (spread) of your cancer?




3. The possible causes of your cancer?




4. Whether the cancer is under control?




5.Whether family members are also at risk of




developing cancer?
6. The purpose of any medical tests you have had




or may undergo?
7. The procedures of the medical tests?




8. The results of the medical tests you have




already received?
9. The medical treatment (chemotherapy,




radiotherapy, surgery or other modality)?
10. The expected benefit of the treatment?




11. The possible side-effects of the treatment?




12. The expected effects of the treatment on




cancer symptoms?
13. The effects of the treatment on social and




family life?
14. The effects of the treatment on sexual




activity?
15. The effects of treatment on fertility (the




ability to have a baby)?
16. Other treatment options?




17. Financial, insurance, work-related or legal




resources?
18. Additional help outside the hospital (e.g. help




with daily activities, self-help groups)?
19. Rehabilitation services (e.g. physiotherapy,




occupational therapy)?
20. Aspects of managing your illness at home?




21. Possible professional psychological support?




22. Different places of care (hospitals/outpatient




services/home)?
23. Things that you can do to help yourself get




well (rest, contact with others…)
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Health Information Received
These are some questions about the different types of information you may have received about
your cancer or treatment. For each type of information, check the box to show how much
information you have received.
Q2. During your current disease or treatment, how much information have you received
on…
Not at all
A Little
Quite a Bit
Very
Much
1. The diagnosis of your cancer?




2. The extent (spread) of your cancer?




3. The possible causes of your cancer?




4. Whether the disease is under




control?
5. Whether family members are also at




risk of developing cancer?
6. The purpose of any medical tests you




have had or may undergo?
7. The procedures of the medical tests?




8. The results of the medical tests you




have already received?
9. The medical treatment




(chemotherapy, radiotherapy, surgery
or other modality)?
10. The expected benefit of the




treatment?
11. The possible side-effects of the




treatment?
12. The expected effects of the




treatment on cancer symptoms?
13. The effects of the treatment on




social and family life?
14. The effects of the treatment on




sexual activity?
15. The effects of treatment on fertility




(the ability to have a baby)?
16. Other treatment options?




17. Financial, insurance, work-related




or legal resources?
18. Additional help outside the hospital




(e.g. help with daily activities, self-help
groups)?
19. Rehabilitation services (e.g.




physiotherapy, occupational therapy)?
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Q2. (continued) During your current disease
or treatment, how much information have
you received on…

20. Aspects of managing your illness at
home?
21. Possible professional psychological
support?
22. Different places of care
(hospitals/outpatient services/home)?
23. Things that you can do to help
yourself get well (rest, contact with
others…)
24. Have you received written
information?
25. Have you received information on
CD or tape/video?
26. Overall, were you satisfied with the
information you received?
27. Do you wish to receive more
information?
27a. If yes, please specify on which
topics?
28. Do you wish you had received less
information?

Not at all

A Little

Quite a Bit

Very
Much

































 Yes

 No

 Yes

 No

 Yes

 No

 Yes

 No

If yes go to question
27a
If no go to question 28

 Yes

 No

If yes go to question
28a
If no go to question 29

28a. If yes, please specify on which
topics?
Not at all
29. Overall has the information you
have received been helpful?



132

A Little


Quite a Bit


Very
Much


Where you Look for Health Information
These questions are about where you look for health information about cancer. For each,
check the box for your answers about where you look for information.
Q3. Have you ever looked for information about health or medical topics from any
source?
 Yes [If yes, go to question 3A]
 No [If no, go to question, go to question 4]
Q3A. The most recent time you looked for information about health or medical
topics, where did you go first? Choose one
a. Books
b. Brochures, pamphlets, etc.
c. Cancer organization
d. Family
e. Friend/Co-Worker
f. Doctor or health care provider
g. Internet
h. Library
i. Magazines
j. Newspapers
k. Telephone information number
l. Complementary, alternative, or unconventional practitioner
m. Other-Specify-
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Q3B. When you look for information about health or medical topics, where did you
go? Choose all that apply
a. Books
b. Brochures, pamphlets, etc.
c. Cancer organization
d. Family
e. Friend/Co-Worker
f. Doctor or health care provider
g. Internet
h. Library
i. Magazines
j. Newspapers
k. Telephone information number
l. Complementary, alternative, or unconventional practitioner
m. Other-Specify-
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Q4. From where do you prefer to receive information about your cancer? Choose one
a. Books
b. Brochures, pamphlets, etc.
c. Cancer organization
d. Family
e. Friend/Co-Worker
f. Doctor or health care provider
g. Internet
h. Library
i. Magazines
j. Newspapers
k. Telephone information number
l. Complementary, alternative, or unconventional practitioner
m. Other-Specify-

Q5. Based on the results of your most recent search for information about health or
medical topics, how much do you agree or disagree with each of the following
statements?
Strongly Somewhat Somewhat Strongly
Agree
Agree
Disagree Disagree
a. It took a lot of effort to get the
information you needed.









b. You felt frustrated during your
search for the information









c.

















You were concerned about
the quality of the information

d. The information found was
hard to understand
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Q6. Overall, how confident are you that you could get advice or information about
health or medical topics if you needed it?
1. Completely confident
2. Very Confident
3. Somewhat confident
4. A little confident
5. Not confident at all
Q7. In general, how much would you trust information about health or medical topics
from each of the following?
Not at all

A Little

Some

A Lot

a. A doctor









b. Family or friends









c.









d. Radio









e. Internet









f. Television









g. Government health
agencies









h. Charitable organizations









i. Religious organizations and
leaders









Newspapers or magazines
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Your Health-Related Quality of Life
These questions ask for your views about your health. These questions are about how you feel
and how well you are able to do your usual activities. Check the box for each question that
describes how you feel.
Q8. In general, would you say your health is:
 Excellent
 Very Good
 Good
 Fair
 Poor
Q9. The following two questions are about activities you might do during a typical day.
Does your health limit you in moderate activities, such as moving a table, pushing a vacuum
cleaner, bowling, or playing golf?
 Yes, Limited A Lot
 Yes, Limited A Little
 No, Not Limited At All
Does your health limit you in climbing several flights of stairs?
 Yes, Limited A Lot
 Yes, Limited A Little
 No, Not Limited At All
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Q10. During the past 4 weeks have you had any of the following problems with your work
or other regular activities as a result of your physical health and . . .
Accomplished less than you would like:
 Yes
 No
Were limited in the kind of work or other activities:
 Yes
 No
Q11. During the past 4 weeks, were you limited in the kind of work you do or other regular
activities as a result of any emotional problems (such as feeling depressed or anxious) and…
Accomplished less than you would like:
 Yes
 No
Didn’t do work or other activities as carefully as usual:
 Yes
 No
Q12. During the past 4 weeks, how much did pain interfere with your normal work
(including both work outside the home and housework)?
 Not At All
 A Little Bit
 Moderately
 Quite A Bit
 Extremely
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Q13. The next three questions are about how you feel and how things have been during the
past four weeks. For each question, please give the one answer that comes closest to the way
you have been feeling. How much of the time during the past 4 weeks –
Have you felt calm and peaceful?
 All of the Time
 Most of the Time
 A Good Bit of the Time
 Some of the Time
 A Little of the Time
 None of the Time
Did you have a lot of energy?
 All of the Time
 Most of the Time
 A Good Bit of the Time
 Some of the Time
 A Little of the Time
 None of the Time
Have you felt downhearted and blue?
 All of the Time
 Most of the Time
 A Good Bit of the Time
 Some of the Time
 A Little of the Time
 None of the Time
Q14. During the past 4 weeks, how much of the time has your physical health or emotional
problems interfered with your social activities (like visiting with friends, relatives, etc.)?
 All of the Time
 Most of the Time
 A Good Bit of the Time
 Some of the Time
 A Little of the Time
 None of the Time
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Questions About You
Q15. What is your gender?
 Male
 Female

Q16. What is your age?

Q17. Are you Hispanic or Latino?
 Hispanic
 Not Hispanic
Q18. What is your race?
 Black or African American
 White or Caucasian
 Asian
 Native American or Alaska native
 Native Hawaiian or Other Pacific Islander
 Multi-racial
 Other
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Q19. What kind of medical insurance coverage do you have?
 None
 Private insurance
 Employer sponsored insurance
 Self-pay
 Medicare
 State-sponsored Indigent Care Program
 Virginia Coordinated Care Program
 Medicaid
 Military
 Not sure
 Other _________________________
Q20. Which of the following best describes your employment status?
 Full-time paid
 Part-time paid
 Retired
 Unemployed
 Homemaker
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Q21. Which category represents your combined total household income during the last 12
months? This includes money from jobs, net income from business, or farm or rent,
pensions, dividends, interest, social security payments, disability and any other money
income received by everyone in your household.
 Less than $5,000
 $5,001 - $10,000
 $10,001 – $15,000
 $15,001 - $20,000
 $20,001 - $25,000
 $25,001 - $30,000
 $30,001- $40,000
 $40,001 - $50,000
 $50,001 - $60,000
 $60,001 - $70,000
 $70,001 - $80,000
 $80,001 - $90,000
 $90,001 - $100,000
 Greater than $100,000
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Thank You!
Comments:

Please return your survey in the enclosed envelope
or use the following address:
Dana Ladd
c/o Robin Matsuyama Ph.D
Box 980149
Department of Social and Behavioral Health
Virginia Commonwealth University
Richmond, VA 23298-0149
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Appendix B
Letters

Research Participant Introductory Letter
<Date>
<Address Line 1>
<Address Line 2>
Address Line 3>
Dear <patient name>:
I am writing to ask for your help with an important research study I am conducting at the
Virginia Commonwealth University Massey Cancer Center. The purpose of this research study is
to find out more about the health information needs and health information sources of patients
who have been diagnosed with cancers that are considered rare. In the next few days you will
receive a request to participate in this project by answering a survey about your health
information needs and the sources of information you use to find health information about
cancer. I hope this study will contribute to improving patients’ access to reliable information
about rare cancers.
We would like to do everything we can to make it easy and enjoyable for you to participate in
the study. I am writing in advance because many people like to know ahead of time that they
will be asked to fill out a questionnaire. This research can only be successful with the generous
help of people like you.
To say thanks, you will receive a small token of appreciation with the request to participate. I
hope you will take 10-15 minutes of your time to help us.
Sincerely,

Dana L. Ladd, MS SLIS
Department of Social and Behavioral Health
Virginia Commonwealth University
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Research Participant Initial Invitation Letter
<Date>
<Address Line 1>
<Address Line 2>
<Address Line 3>
Dear <patient name>:
I am inviting you to participate in a research study I am conducting at the Virginia
Commonwealth University Massey Cancer Center. You are being contacted because you have
been diagnosed with a cancer that is considered rare and your physician agreed this was a study
for which you are potentially eligible. Your participation will not interfere with any care or
treatment you may be receiving at this time. The purpose of this research study is to find out
more about the health information needs and health information sources of patients who have
been diagnosed with rare cancers.
You are being asked to complete a written survey about your health information needs. The
questions take about 15 minutes to complete. Your responses are voluntary and will be kept
confidential. By completing and returning the survey you are consenting to participate in this
research study. If you have any questions about this study, please call Dana Ladd at 804-6282429 or email at dlladd@vcu.edu. Data are being collected only for research purposes. All
personal identifying information will be kept in password-protected files on a secure server.
Your data will be identified by ID numbers, not names, and stored separately from research data
in locked files in the researcher’s office. Although the study team has put in safeguard to protect
your information, there is always a potential risk of loss of confidentiality. We will not tell
anyone the answers you give us and we will not use your name when we are reporting on the
study. This study has been reviewed and approved by the Virginia Commonwealth University
Institutional Review Board, and if you have any questions about your rights as a participant in
this study, you may contact them by telephone at 804-827-2157.
You may not receive any direct benefit from this study, but by taking a few minutes to share
your thoughts about your health information needs, you will help us in improving access to
reliable health information about rare cancers. If you wish to participate in this study, please
complete the enclosed survey and mail back to us in the enclosed addressed stamped envelope.
A small token of appreciation is enclosed as a way of saying thank you.
Your alternative is to not participate in the study. Your care at Massey Cancer Center will not be
affected by whether or not you participate in the study. If you do not wish to participate in the
study, you may opt out of receiving any future letters by emailing dlladd@vcu.edu or calling
Dana Ladd at 628-2429.
I truly appreciate your time and help with the study.
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Sincerely,
Dana L. Ladd, MS SLIS
Department of Social and Behavioral Health
Virginia Commonwealth University
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Research Participant Reminder Letter
<Date>
<Address Line 1>
<Address Line 2>
Address Line 3>
Dear <patient name>:
Last week a questionnaire was mailed to you asking you to participate in a study about the health
information needs of patients diagnosed with cancers that are considered rare.
If you have already completed and returned the questionnaire, please accept our sincere thanks.
If not, please consider completing and returning the survey as soon as possible. We are
especially grateful for your help with this important study. If you did not receive the
questionnaire, if you have any questions about this study, or if you do not want to receive any
future letters about this study, please call Dana Ladd at 804-628-2429 or email at
dlladd@vcu.edu.

Sincerely,

Dana L. Ladd, MS SLIS
Department of Social and Behavioral Health
Virginia Commonwealth University
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Research Participant Information (Follow-up) Letter
<Date>
<Address Line 1>
<Address Line 2>
Address Line 3>
Dear <patient name>:
In <insert date> we sent you a letter requesting that you complete a questionnaire about your
cancer health information needs. To the best of our knowledge, it has not yet been returned.
We are writing again because of the importance that your feedback can provide to our study
about patients’ health information needs. We hope that you will fill out and return the enclosed
questionnaire as soon as possible.
As mentioned before the questions take about 15 minutes to complete. Your responses are
voluntary and will be kept confidential. If you have any questions about this study, please call
Dana Ladd at 804-628-2429 or email at dlladd@vcu.edu. This study has been reviewed and
approved by the Virginia Commonwealth University Institutional Review Board, and if you have
any questions about your rights as a participant in this study, you may contact them by telephone
at 804-827-2157. By completing and returning this survey, you are consenting to participate in
this research study.
Thank you for your time and help with this research study.

Sincerely,

Dana L. Ladd, MS, SLIS
Department of Social and Behavioral Health
Virginia Commonwealth University
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Research Participant Information Final Letter
<Date>
<Address Line 1>
<Address Line 2>
Address Line 3>
Dear <patient name>:
I am writing one last time to thank you for participating in the Health Information Needs study.
The responses we have received have been invaluable. If you have not yet had a chance to send
us your responses, you are welcome to do so and we would still appreciate your help completing
the survey. We will continue to accept questionnaires until <date> at which point we will move
to the next stage of the study.
If you have any remaining questions about this survey of cancer health information needs, I will
be happy to help and can be reached by telephone at 804-628-2429 or by email at
dlladd@vcu.edu.
I truly appreciate your time and help with the study.
Sincerely,

Dana L. Ladd, MS, SLIS
Department of Social and Behavioral Health
Virginia Commonwealth University

150

Appendix C
Cancer Types, Sites, and Stage by Demographics
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Table 14: Cancer histology group and behavior descriptions of study participants by
demographics
Histology Group Description
Histology Behavior Description

Acinar Cell Carcinoma
Acinar cell carcinoma
Adenocarcinoma with Metaplasia
Metaplastic Carcinoma
Metaplastic Carcinoma
Adenocarcinoma, NOS
Adenocarcinoma, NOS
Adenocarcinoma, NOS
Adenocarcinoma, NOS
Adenoid Cystic & Cribriform CA.
Adenoid Cystic Carcinoma
Adenoid Cystic Carcinoma
Astrocytoma, NOS
Astrocytoma, anaplastic
Astrocytoma, anaplastic
Carcinoid Tumor, Malignant
Carcinoid Tumor, Malignant
Carcinoid Tumor, Malignant
Carcinoid Tumor, Malignant
Carcinoid Tumor, Malignant
Carcinoid Tumor, Malignant
Carcinoid Tumor, Malignant
Carcinoid Tumor, Malignant
Neuroendocrine carcinoma
Neuroendocrine carcinoma
Merkel cell carcinoma
Merkel cell carcinoma
Goblet Cell Carcinoma
Carcinoma, NOS
Carcinoma, NOS
Carcinoma, Undiff., NOS
Pleomorphic carcinoma
Carcinosarcoma, NOS
Carcinosarcoma, NOS
Cholangiocarcinoma
Cholangiocarcinoma
Cholangiocarcinoma
Chronic Myeloproflierative Dis.
Myelosclerosis w/myeloid
metaplasia
Essential thrombocythemia
Essential thrombocythemia
Clear Cell Adenocrcinoma, NOS
Clear Cell Adenocarcinoma, NOS
Clear cell adenocarcinoma, NOS
Renal Cell Carcinoma,
Chromophobe type
Cystadenocarcinoma, NOS
Serous cystadenocarcinoma,NOS
Endometrioid Adenocarcinoma
Endometrioid carcinoma
Endometrioid carcinoma
Erythroid Leukemia
Acute myeloid leukemia, M6

Primary Cancer Site

Derived
Stage
(AJCC
V7)

Derived
Stage
Grouped

Gender
M=Male
F=Female

Age

Race
W=White
NW=NonWhite

Parotid gland

III

III

F

63

NW

Breast
Breast

IIIB
IIIA

III
III

F
F

63
49

W
NW

Endocervix
Ileum
Duodenum

IIIB
IV
IV

III
IV
IV

F
F
M

33
67
73

W
W
W

Cheek mucosa
Overlapping lesion
breast

I
IIA

I
II

F
F

65
72

W
NW

Frontal lobe
Parietal lobe

NA
NA

NA
NA

M
F

58
35

W
NW

Rectum, NOS
Rectum, NOS
Ileum
Ovary
Ileum
Ileum
Small Intestine
Gallbladder
Ovary
Skin-upper limb
Skin-scalp/neck
Appendix

I
UNK
IIIB
IA
IIIA
IIA
IIIB
NA
IV
IIB
UNK
IIA

I
UNK
III
I
III
II
III
NA
IV
II
UNK
II

M
F
M
F
F
F
F
F
F
F
M
F

76
62
62
66
68
69
61
55
26
74
68
59

NW
NW
W
W
NW
W
W
NW
W
NW
W
W

Parotid Gland

IVC

IV

M

60

W

Parotid Gland

IVC

IV

M

72

W

Endometrium

IIIA

III

F

78

NW

Biliary Tract, NOS
Intrahepatic bile duct

NA
II

NA
II

M
M

42
73

W
W

Bone Marrow

NA

NA

F

56

W

Bone Marrow
Bone Marrow

NA
NA

NA
NA

F
M

41
68

W
NW

Cervix uteri
Upper lobe, lung
Kidney

IB1
IB
I

I
I
I

F
M
F

39
71
68

W
W
W

Fallopian Tube

IA

I

F

55

W

Cervix Uteri
Ovary

IVB
IIIA

IV
III

F
F

67
74

NW
W

Bone Marrow

NA

NA

F

53

W
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Ewing Sarcoma
Ewing Sarcoma
Ewing Sarcoma
Fibromatous Neoplasms
Fibrosarcoma
Solitary Fibrous tumor, malignant
Fibromyxosarcoma
Fibromyxosarcoma
Fibromyxosarcoma
Fibromyxosarcoma
Fibrous Histiocytoma, Mal.
Dermatofibrosarcoma, NOS
Dermatofibrosarcoma, NOS
Follic. & Marginal Lymh, NOS
Follicular lymphoma, NOS
Marginal zone B-cell lymphoma
Glioblastoma, NOS
Gliosarcoma
Glioblastoma, NOS
Glioblastoma, NOS
Glioblastoma, NOS
Glioblastoma, NOS
Hemangioendothelioma
Epitheloid
Hemangioendothelioma
Immunoproliferative Diseases
Waldenstrom macroglobulinemia
Kaposi Sarcoma
Kaposi Sarcoma
Liposarcoma Neoplasms
Myxoid Liposarcoma
Lymphoepithelial Carcinoma
Basaloid squamous cell
carcinoma
Basaloid squamous cell
carcinoma
Malignant Lymphoma, NOS
Primary Cutaneous Follicle
Centre Lymphoma
ML, Large B-Cell, Diffuse
Burkitt Lymphoma, NOS
ML, Large B-cell, diffuse
ML, Large B-cell, diffuse
ML, Large B-cell diffuse
ML, Small B-Cell Lymphocytic
Mantle cell lymphoma
Mantle cell lymphoma
Mucinous Adenocarcinoma
Mucinous Adenocarcinoma
Mucoepidermoid Carcinoma
Mucoepidermoid Carcinoma
Myeloid Leukemia, NOS
Chronic Myeloid Leukemia

Long Bones/upper
limb
Pelvic Bones

IIA

II

M

31

NW

IVA

IV

M

20

W

Connective,
subcutaneous
Connective,
subcutaneous
Connective,
subcutaneous

III

III

M

77

W

IIB

IIB

F

40

W

III

III

M

77

W

IIA
IIB
III

II
II
III

F
M
M

69
79
53

W
W
NW

Skin of trunk
Vulva, NOS

NA
NA

NA
NA

F
F

35
63

NW
NW

Small intestine, NOS
Ethmoid sinus

IIEA
IIEA

II
II

M
M

65
73

W
W

Temporal Lobe
Frontal Lobe
Parietal Lobe
Parietal Lobe
Temporal Lobe

NA
NA
NA
NA
NA

NA
NA
NA
NA
NA

M
M
M
M
M

62
83
47
78
53

W
W
W
NW
W

Liver

NA

NA

F

60

W

Blood

NA

NA

M

72

W

Skin, NOS

NA

NA

M

41

NW

Connective,
subcutaneous

IB

I

F

67

W

Base of tongue, NOS

IVA

IV

M

50

W

Larynx, NOS

IVA

IV

M

58

W

Skin of scalp and
neck

IE

I

F

74

NW

Breast NOS
Connective,
subcutaneous
Connective
Short bones/lower
limb

IEA
IEA

I
I

F
F

36
35

NW
W

IIEA
IEA

II
I

M
M

93
60

NW
W

Lymph
nodes/multiple
regions
Palate, NOS

IVB

IV

M

70

W

IEA

I

F

46

W

Lower lobe, lung

IB

I

M

63

W

Parotid Gland

I

I

F

50

W

Bone Marrow

NA

NA

M

71

W
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Chronic Myeloid Leukemia
Myomatous Neoplasms
Leiomyosarcoma, NOS
Leiomyosarcoma, NOS

Leiomyosarcoma, NOS
Leiomyosarcoma, NOS
Neurofibrosarcoma
Malignant peripheral nerve sheath
tumor
Nevi & Melanomas
Malignant Melanoma
Nonencapsul. Sclerosing Ca.
Nonencapsulating sclerosing
carcinoma
Oligodendroglioma, NOS
Oligodendroglioma, NOS
Oligodendroglioma, anaplastic
Osteosarcoma, NOS
Osteosarcoma, NOS
Chondroblastic osteosarcoma
Other Leukemias
Hairy cell leukemia
Hairy cell leukemia
Other Myeloid Leukemias
Chronic myelogenous leukemia,
BCR/ABL pos
Chronic myelogenous leukemia,
BCR/ABL, pos
Other Spec. Non-Hodgkin
Lymphoma
NK/T-cell lymphoma, nasal and
nasal type
Anaplastic large cell lymphoma,
T-cell and
Oxyphilic Adenocarcinoma
Oxyphilic adenocarcinoma
Paget Disease, Extramammary
Paget disease, extramammary
Paget disease, extramammary
Papillary & Follicular Adenoca.
Mixed medullary-papillary
carcinoma
Papillary Carcinoma, NOS
Verrucous carcinoma, NOS
Papillary squamous cell
carcinoma
Papillary Cystadenoca., NOS
Intraductal papillary-mucinous
carcinoma
Phylllodes Tumor, Mal.
Phyllodes tumor, malignant
Polycythemia Vera
Polycythemia vera
Prolymph/Precurs Leukemia
Prolymphocytic leukemia, T-cell
type

Bone Marrow

NA

NA

M

44

W

Connective,
subcutaneous
Connective,
subcutaneous
Mandible
Connective,
subcutaneous

IIB

II

F

42

NW

IIA

II

F

65

W

IIA
III

II
III

F
F

36
59

W
W

Peripheral nerves and
autonomic

IA

I

M

44

W

Partotid gland

NA

NA

M

61

W

Thyroid gland

I

I

F

19

W

Frontal Lobe
Frontal Lobe

NA
NA

NA
NA

F
M

46
33

W
W

Bones of skull and
face
Vertebral column

IA

I

M

84

NW

IVB

IV

M

19

W

Bone marrow
Bone marrow

NA
NA

NA
NA

M
M

77
41

W
W

Bone marrow

NA

NA

F

77

NW

Bone marrow

NA

NA

F

56

W

Nasal cavity

IEA

I

F

64

W

Ethmoid sinus

IVA

IV

F

86

W

Thyroid gland

II

II

F

56

NW

Skin of trunk
Skin of trunk

Unk
II

Unk
II

M
M

59
65

W
W

Thyroid Gland

IVA

IV

M

79

W

Ventral surface of
tongue
Pharynx, NOS

I

I

F

69

W

NA

NA

M

36

W

Head of pancreas

IA

I

F

64

NW

Breast, NOS

IIA

II

F

91

NW

Bone marrow

NA

NA

M

69

W

Bone marrow

NA

NA

M

68

W

Bone marrow

NA

NA

M

59

NW
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Prolymphocytic leukemia, T-cell
type
Refractory Anemia
Refractory anemia with excess
blasts
Refractory anemia with excess
blasts
Refractory anemia with excess
blasts
Sarcoma, NOS
Giant cell sarcoma
Squamous Cell Carcinoma
Sq. cell carcinoma, keratinizing,
NOS
Sq. cell carcinoma, keratinizing,
NOS
Sq. cell carcinoma, keratinizing,
NOS
Sq. cell carcinoma, keratinizing
NOS
Sq. cell carcinoma, spindle cell
Sq. cell carcinoma spindle cell
Sq. cell carcinoma, lg. cell, nonker
Stromal Sarcoma
Adenosarcoma
Sweat Gland Adenocarcinoma
Apocrine adenocarcinoma
Thymoma, Malignant
Thymic carcinoma, NOS

Bone marrow

NA

NA

F

58

W

Bone marrow

NA

NA

F

59

NW

Bone marrow

NA

NA

M

78

NW

Connective,
subcutaneous

III

III

F

68

NW

Vulva

IVA

IV

F

53

W

Overlapping lesion
nasopl
Ovary

III

III

F

41

W

IIB

II

F

55

NW

Vulva, NOS

IB

I

F

49

W

Vagina
Glottis
Nasopharynx, NOS

III
I
III

III
I
III

F
M
M

63
74
23

NW
W
W

Endometrium

IA

I

F

58

W

Upper outer quadrant
of bre

IA

I

F

58

NW

Thymus

NA

NA

F

73

W

Table 15: Histology group descriptions by gender and race
Histology Group Description
54 Types of Rare Cancers

Acinar Cell Carcinoma
Adenocarcinoma with Metaplasia
Adenocarcinoma, NOS
Adenoid Cystic & Cribriform CA.
Astrocytoma, NOS
Carcinoid Tumor, Malignant
Carcinoma, NOS
Carcinoma, Undiff., NOS
Carcinosarcoma, NOS
Cholangiocarcinoma
Chronic Myeloproflierative Dis.
Clear Cell Adenocrcinoma, NOS
Cystadenocarcinoma, NOS
Endometrioid Adenocarcinoma
Erythroid Leukemia
Ewing Sarcoma
Fibromatous Neoplasms
Fibrous Histiocytoma, Mal.
Follic. & Marginal Lymh, NOS
Glioblastoma, NOS
Hemangioendothelioma
Immunoproliferative Diseases
Kaposi Sarcoma

Gender

Race

Male

Female

White

0
0
1
0
1
3
1
1
0
2
1
1
0
0
0
2
4
0
2
5
0
1
1

1
2
2
2
1
9
0
0
1
0
2
2
1
2
1
0
2
2
0
0
1
0
0

0
1
3
1
1
7
1
1
0
2
2
3
1
1
1
1
5
0
2
4
1
1
0
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NonWhite
1
1
0
1
1
5
0
0
1
0
1
0
0
1
0
1
1
2
0
1
0
0
1

Liposarcoma Neoplasms
Lymphoepithelial Carcinoma
Malignant Lymphoma, NOS
ML, Large B-Cell, Diffuse
ML, Small B-Cell Lymphocytic
Mucinous Adenocarcinoma
Mucoepidermoid Carcinoma
Myeloid Leukemia, NOS
Myomatous Neoplasms
Neurofibrosarcoma
Nevi & Melanomas
Nonencapsul. Sclerosing Ca.
Oligodendroglioma, NOS
Osteosarcoma, NOS
Other Leukemias
Other Myeloid Leukemias
Other Spec. Non-Hodgkin
Lymphoma
Oxyphilic Adenocarcinoma
Paget Disease, Extramammary
Papillary & Follicular Adenoca.
Papillary Carcinoma, NOS
Papillary Cystadenoca., NOS
Phylllodes Tumor, Mal.
Polycythemia Vera
Prolymph/Precurs Leukemia
Refractory Anemia
Sarcoma, NOS
Squamous Cell Carcinoma
Stromal Sarcoma
Sweat Gland Adenocarcinoma
Thymoma, Malignant
TOTAL:

0
2
0
2
1
1
0
2
0
1
1
0
1
2
2
0
0

1
0
1
2
1
0
1
0
4
0
0
1
1
0
0
2
2

1
2
0
2
2
1
1
2
3
1
1
1
2
1
2
1
2

0
0
1
2
0
0
0
0
1
0
0
0
0
1
0
1
0

0
2
1
1
0
0
1
2
1
0
2
0
0
0
51

1
0
0
1
1
1
0
0
2
1
5
1
1
1
62

0
2
1
2
0
0
1
1
1
0
5
1
0
1
79

1
0
0
0
1
1
0
1
2
1
2
0
1
0
34
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